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A NEW APPROACH TO THE WArILY DETECTION OF DIALYSIS
DEMLNTIA
P.Ackrill, J.Parron, S.Whiteley, A.C.Horn,
A. 0. Ralston
A.K.U., Withington Hospital, ?iaocliester, U.K.
Sceech disorders are prominent among syspiora
of dialysis dementia. A 20 ulnute screening
osseesment has been daviacd to detect vnnious
abnornalities of speech and mental function.
51 patients have bean interviewed by a speech
theraoist on at least 3 occasiona using this
orotocol during a 2 year follow op. All patients
had been on home self—supervised haenodialysia
for between 1 and 9 years before admission to the
study.
A retrospective and prospective mnslyais of
the notoral aluminium content of the domestic
water supply to these patients was made together
with documentation of the presence or absence of
aluminium sulphate (slum) treatment, a dc—inniser(0) or a water softener (5).
Abmormslities of speech and mentition were
found in 23 patients. Of theme 16 were found to
have received alum treated water for greater than
2 years withoot D or S and 3 others for less thsn
2 years. Of the former group 10 had severe
abnormalities but in only 3 was this appreciated
prior to formal assessment. 3 have died, 2 of
dinlymis dementia, and 3 have shown marked im-
provement mince installation of a de—toniser.
Formal emsemsmgnt of speech and mental function
appears valuable for the early detection of
dialysis dementia and am an objective memos of
follow up. This study adds further support to the
theory that dimlysste aluminium is related to
dialysis dementia.
FCYVANN NEP'rfRITIS Cr eATS: is A vAscpret4EA5ILITY CCHANISM
REALLY NEEDED FOOl IfIUNE cce?LEXES DEPOSITION?
F'. Atonsa, J. Ecieo H. Sanchez crespo, L. Hernnnda.
Fundoci6n jjll2YSfoz, Madrid, Spain.
Au increase o' vascular permeability induced by the re-
lease vasonctive amines from platelets,trig;ered by Igt—
sensitized bosophils,seems necessary far the deposition of
irrenune compleces in ncuce serum sirkness in rabbits. In this
model we hove shown that Disedium Oronoglytote (msca) pre-
vents the development of nephritis in some animals. The aim
of this work was to study the presence of a ssm:lor onophy—
lactic dependent amchanism in rots and ith possible inhibi-
tion by DSCD and Antihistomines (As). Heynonn nephritis was
induced in SO hdistor rats by intcnperitonrol injections of
FdA antigen. The animals weredidtributed in three groups.
Group 1: control rots, Group 2: rats treated with DICG and
Group 31 rats treated with emma and AR. Tee eoistence of
homocytotropic ontibodies (IgE and IgGo) was searched by pa-
ssive cutaneous onaphyloois. Histamine ace egc (Platelet Ac-
tivating Factor) release was studied in the buffy coot cells
(ecc) and kidney homogenotrs challenged by specific antigen,
calcium ianophoro and oymoson. Kidney biopsies, protcinuria
and renal anti—tubule antibodies were studied every 2 wt.
The production of renal anti—tubule antibodies, frecuen-
cy of nephritis and quontity of ieeiuhe deposits in the gb—
merular bosenent membrane, was similar in oil groups. No ani-
mal produced onophylottic onttbodies. No histvrnine ond PAS'
releose 'were obtoinnd when bCO was cholle9ged with hpeccfic
antigen. Totol histomine otter boiling 10 bcc was less thon
20 ng.
Our results show thot, contrary Eu whvt has been 5055cm
ted, there is no active onophyloctic dependent mechonism in
the Heymonn nephritis. furthernore, thn srcrce tuontities of
histamine in bOO mates unlibely that histrmsne could ploy
any role in other models of rot nephritis.
A full account of the meeting will appear in the Proceedings of
the EDTA. AB Gambro (Sweden) has kindly assisted with the
publication of the abstracts. Only those abstracts selected for
oral or poster presentation are included here,
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INTRACELLULAR FREE AMINO ACIDS IN PATIENTS TREA-
TED WITH REGULAR HEMDDIALYSIS (Hi))
A.Alvestrand, 0. HergetrHm, P.FDrst
Opt of Nephrology and Metsbolic Research Labora-
tory, S:t Eriks sjukhus, Stockholm, Sweden
Uremic patients (non dialyzed as well as dia-
lyzed) may exhibit abnormal plasma sminograms and
other signs of protein malnutrition. We studied
ftee amino acids in plasma and muscle tissue, ob-
tained by percutaneous needle biopsy, in 9 pat.
on regular ND for more than 6 months. They were
all in good clinical condition and were allowed a
liberal protein intake ( 1 g/kg BR/day). The con-
centration of each amino acid (APi) in intracellu-
lar muscle water was calculated using the chlo-
ride method for assessing the extra/intracellular
water distribution.The intracellular concentra-
tion of all essential amine acids (EAA)were nor-
mal. The conc. of asparatate and proline were
elevated whereas the cone. of asparegine was low.
In plasma the cone. of threonine, methienine and
histidine were high as were the cone. of several
non—essential amino acids (NEAA) . The results
contrast with earlier findings in patients on
regular peritoneal dialysis and nun—dialyzed ure—
mic patients who demonstrated gross abnormalities
in intracellular or extracellular cone. of seve-
ral EAA and NEAA (especially low valine and thre—
onine). In conclusion, the abnormalities in int-
racellular cone, of free AA may be reversed by
ND treatment and adequate nutrition. Thus, ND
patients who are able to eat well appear not to
require additional supply of EAA or analogues.
IHIAZIDE DIURETICS IN RENAL HYPERCAJCIUIITA
A.Aroldi, G.Graziani, G.Mioni, 14.Cecchettin, D.
Drancaccio, C,Galmozzi, M.Surian, A.Cantaluppi
Renal Unit,Milano,Ddine and Erescia Hospital Italy
Fnurty—six "Renal"hyparcalciuric nnrmneslccmic
pts. ware treated wiih Iiydruchloruthiazide (IICT)
5Dmg/day for 6—48 munmhs(mean i8 months) both to
reduce new stone formation and to supprass para
thyroid hyperfunction. while 41 patients chewed a
reduction of hypercalciuria,nurmalizatinn of hio
chemical signs of hyperparathyroidism)HPTII) and
no modification of serum calcium levels, the other
5 patients had no reduction of hypercelciuria and
developed hypercslcemia(ll.6÷D.Smg/dl versus 9,98
P<0.0l).Aftar withdrawal of IICT trcetaent
in these 5 ptm. further metaholic studies were per
formed which showed a strong increment of: Intesti
sal cslcium absorption(78.6-i-23.2% of the administe
red dose,normal value 38±7) ,Exehanpcahlc calcium
pcel(152+l6 L, n,v.65-rlS),Bene accretion rate
(11.0+4.2 L, n.v.5-4-1).Even immuneresctive PTH(2.l
÷0.5 ng/ml,n.v.D.32-eD.18)and urinary Dll—Prnline/
Creatinine ratio)0.42÷0.2 ag/m/24h, n.v.a14-i-0,D8)
were significantly elevated.Four af the five pts.
underwent parathyrnidectemy which corrected the
hypercalcemi a.
In conclusion, the appearance of hypercalcemia
in "Renal" hypercalciuric patients during lid
treatment may be of diagnostic value in unmasking
nun pharmacologically suppresmihle normocalcemic
hypcrparsthyreidi mm.
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NON A, NON B HEPATITIS: A NEW SYNDROME REPORTED
IN HEMODIALYSIS PATIENTS
M.M. Avram, D.A. Feinfeld and A.C. Gan (Intr.
by N.J. Gurland)
The Long Island College Hospital, Long Island,USA
We have recently observed a new form of hepa-
titis in which serological tests for infection
with hepatitis A and B viruses are negative in di-
alysispts. As hepatitis is a major problem in
hemodialysis patients, we studied 100 uremic pa-
tients, retrospectively and prospectively, for
evidence of a linking set of findings in this set-
ting. Five patients on stable hemodialysis had 1-4
month episodes of the following symptoms: nausea,
vomiting, weakness,malaise, low grade fever. Concomi-
tant with this constellation, they had increased fre-
quency of intradialytic hypotensive episodes and
anorexia, with an average dry weight loss of 5 lb.
while symptomatic. Two of 15 patients had never
received transfusions. All 5 patients during the
time of illness had elevations of SGPT ranging
from 122—953 u/ml. SGOT was less consistently
elevated and bilirubin was normal. Screening of
these patients' sera for hepatitis B antigen and
anti-hepatitiS A and B antibodies was uniformly
negative, as was testing for cytomegalovirus,
herpes and Epstein-Barr virus.
We conclude that hemodialysis patients, in
addition to classical hepatitis, may develop non-
A, non-B hepatitis, with anicteric hepatic in-
flammation and C—I symptoms, as described above,
as an integral part of this new syndrome. SGPT
determination and hepatitis virus testing to
establish this diagnosis should be done on hemo-
dialysis patients with unexplained fever and
nausea, or with increasing frequency of hypoten—
sion during dialysis.
PATHOGENETIC ROLE OF MESANGIAL IMMUNE DEPOSITS
S.Batsford, H.Takamiya, R.Rohrbach, A.Vogt (Intr.
by R.Kluthe).
Hygiene and Pathology Institutes, Freiburg, FRG.
The work reported here was aimed at clarifying
the pathogenetic role of immune processes within
the mesangium. Previous work in this field is con-
tradictory; Mauer et al (.l.Exp.Med.137,553,1973),
using a model involving aggregated IgG and renal
transplantation, reported a deleterious effect on
glomerular function, whilst Germuth et al(Lab.
Invest.38,404,1978) with a toxic antigen (thyro—
globulin) saw little damage.
In our system an antigen (ferritin—IgG conju-
gate) is taken up and persists for up tol8months
within the mesangium, but is rapidly cleared from
the blood. Subsequent administration of rabbit
anti—ferritin antibody resulted in heavy binding
of antibody to the mesangially located antigen.
Groups of rats received ferritin—IgG followed
by anti—ferritin or normal rabbit serum, as a con-
trol, respectively. No urinary abnormalitieswere
seen in an 18 month period. By light microscopy
both groups revealed swollen and increased num-
bers of endothelial and mesangial cells, mainly in
the first week, at 4 weeks and later all kidneys
were normal. Immunofluorescence confirmed the per-4
sistance of antigen for up to 18 months in both
groups.
The early morphological changes presumably re-
flect the effect of antigen alone, as they were
similar in both groups. These results lend sup-
port to the view that an immunological process,
confined to the mesangium, may not necessarily
compromise glomerular function.
A NEW STERILE CONNECTING SYSTEM FOR TO AVOID PERI-
TONITIS IN CAPD
H.Becker, R.Schurig, K.Affeld, A.Mohnhaupt, F.
Zartnack, J.Frank
Free University Berlin, Nephrological Department
im Klinikum Charlottenburg
Peritoneal dialysis ist not widely used for the
treatment of end stage renal failure. The intro-
duction of continous ambulatory peritoneal dia-
lysis (CAPD) by Popovich and Oreopoulos shows a
new trend in dialysis treatment. One main limita-
tion for the CAPD is the high incidence of peri-
tonitis because of frequent connecting and dis-
connecting of the fluid bags. For to avoid bac-
terial contamination during the changing procedure
we developed a special connector which ensures a
sterile pathway between the peritoneal cavity and
fhè fFufdThag. The main feature of the connectors
are ends which are recessed in a shieldjj in
such a way that the not be contacted in
advertendly. Both the male and female part of the
connector have this shielding and both parts fit
teleskopically into each other. In addition one
connector contains a sponge with a desinfecting
agent to avoid any contamination. The sponge
slides over one end of the cone and desinfects
its immediate surrounding. The connectors with the
sponge is attached to the fluid ba and is dis-
posable. The other connector remains with the
patient. The handling of the connector is easier
than that of the systemsused today in the clinic.
The connector is only a small component, but
as peritonitis is a main complication in perito-
neal dialysis, its development and presentation
seems to be justified.
HLA Bw35 ANTIGEN ANI) MESANGIAL IgA GLOME-
RULONEPHRITIS:A POOR PROGNOSIS MARKER?
F.C. Berthoux,C. Genin,A. Gagne,J.C. Le
Petit,and J.C. Sabatier.
Service de Néphrologie,Hôpital de Belle-
vue, 42100 SAINT-ETIENNE, France.
Familial cases of mesangial IgA glome-
rulonephritis(MGN) have raised the possi-
bility of a genetic control in this dise-
ase.In 50 patients with MGN,diagnosed on
renal biopsy..and in 105 controls,we have
compared the distribution of HLA antigens
(A and B loci) .We found a significant in-
crease in the frequency of HLA Bw35 anti-
gen in the patients group(35% versus 13%;
P<O.O2).There was no significant diffe-
rence between the Bw35 positive and nega-
tive MGN subgroups,on clinical, serologi-
cal,and pathological data.Both subgroups
had elevated mean serum IgA(l54% of nor-
mal),but also mean serum IgM(l46%).
However,the follow—up data exhibited a
significantly worse prognosis (P<0.01) in
the Bw35 positive subgroup:9 out of 18
ptj,ent yerua 4 out of 32 progressed to
chronic renal failure(serum creatiriine>
1.Smg/dl).
So,we have established a genetic lin-
lcage between FILA complex and MGN occur-
rence.The Bw35 antigen 'flay serve as a
marker(risk to be diseased=4),and more
precisely for poor prognos±s cases.
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NECROTIZING CUTANEOUS VASCULITIS CAUSED
BY PVC PLASTIC TUBING
J.Bommer, E.Ritz
Dept. Interri.Med. , Heidelberg,Germany(FRG)
A 59 year male patient with polycystic
disease without history of atopy or aller-.-
gy was dialysed since 197o,using PVC tu—
bing and dialysers of one single manufac—
turer.Starting in 1974,recurrent bouts of
intensely itching papules occured with
each dialysis.Histology revealed necroti-
zing arteriitis;immunohistology showed de-
position of immunoglobulins and complerrent
There were no systemic signs and symptoms
and evidence of visceral involvement.Cuta—
neous testing gave negative results for
all commercially available heparin prepa-
rations and heparin preservatives.Epicu—
taneous patch tests with used PVC tubing
were positive.The lesions persisted des-
pite changing the dialyser and using a so.-
ries of plate and capillary dialysers.In
contrast,dialysis with polyurethane coa-
ted tubing caused cessation of the cuta-
neous lesion which reappeared after re—
exposure to plain PVC tubing.
More information on the frequency of
sensibilisation against PVC is necessary,
but coating of PVC tubing with polyure-
thane may generally be advisable in hemo—
dialysis equipment.
PROPRANOLOL ( PR ) AND UREMIC OSTEODYSTROPHY.
D,Brancaccio, C.Galmozzi, S.Casati, D.Rurale,
S.Belloli*, A.Aroldi, G.Graziani, C.Ponticelli.
Renal Unit,Policlinic Hospital,Milan,Italy.
*Lab. of Chemistry, E.U.L.0.,Brescia,ltaly.
An inhibiting effect of Beta 2 blocking agents
on PTH secretion has been recently supported by
in vitro and in vivo experiments.In order to in—
vestigate the possible role of PH for the treat—
mOnt of renal osteodystrophy,plasma PTIJ,Alkaline
Phosphatase,0H Proline,calcium,phosphate,x—Ray
semiquantitative evaluation of bone resorption
were assessed in 66 patients on regular dialysis
treatment.The patients were divided in two groups,
homogeneous for age,aex,duration of dialysis and
dialysis schedule.
33 patients never received PR and 33 were treated
by PR for 4—60 months with a mean oral dose of
120 mg daily.
Alk.Phosphatase and plasma 0H-Proline were signi
ficantly (P(o.000i) lower in the treated group
while PTH levels, although lower in treated pa—
tients,did not show significsnt difference be—
twenn the two groups (7703 5283 vs 10565 3999
pg/ml). Rx bone resorption was less frequent in
patients taking PR (5/15)than in cortrols(22/28).
These data seem to suggest a possible role for
propranolol in inhibiting urersic hyperparathyroi—
dism.
RENAL OSTEODYSTROPHY IN CHILDREN:THERAPY







Growth arrest and renal osteodystrophy
is a major problem in renal insufficiency
of children.The present report describes
our experiences in managing renal osteo—
dystrophy in 11 children in progressiv
renal failure and 16 children on main-
tained hemodialysis treatment by using
vitamin 03 for 12 to 24 months and in 14
dialyzed children by using l,25-DHcc for
l2months. In treatment with vitamin D no
hypercalcemia was seen .Plasma—ca , alkaine
phosphatase,1PTH and radiographic abnor-
malities improved.Bone biopsies showed
improvement in signs of secondary hyper—
parathyreodism ,osteomalacia remained un-
changed and osteoblast population showed
a small reduction.Intreatment with 1,25-
DHCC severe but reversible hypercalcemia
occured .Alkaline phosphatase , iPTH and
radiographic bone disorders revealed mar-
ked improvement.Histological signs of
fibroosteoclasia and resorptive defects
disappeared only .Osteoblast population
and + bone transformation was obvious
reducted.Vitamin D and 1,25-DHCC failed
to normalize growt. Summarizing ,neither
vitamin D3nor 1,25-DHcC can guarantee
complete recovery of renal osteodystrophy
and of growth arrest in uremic children.
HEMDDYN1HIC DAWERS OF HIGH FLaJ P.RZERIO-VEDUS
FISTULASL. Burrows, K. Kwun, H. Schanzer, M. Hainov
MDunt Sinai lical Center, New York, U.S.A.
The shunting of large volunes of blocxl fran
the arterial to the venous tree under Patio—
logical circumstances can lead to serious Iwaio
and cardio damic alterations. This stndy
analyzed a series of deliberately constructed
arterio-venous fistulas for headialysis to
ascertain whether similar alterations can occur.
In a series that exceeds 1000 angioaccessprocedures, 40 patients at randcxn were sbxlied.
20 underwent standard arterio—venous fistulas
(AVF) at the wrist and 20 arterio-venous
grafting (Bovine or Gortex) in the upper arm
(brachial artery to axillaxy vein). J½ngioaccessflow rates were treasured with an electranagnetic
square wave flow neter and cardiac outputs
treasured by dye dilution techniques. AVF flow
rates averaged 280cc/minute with approximately20% of flow caning fran the distal artery. This
access technique bad a minimal effect on cardiac
output or arterial stealing. lbwever, large
diter (greater than 6. Sirni) high flow (1500-
2000cc/mm) grafts often lead to high cardiac
output rates (9-15 liters/nin) and resulted in
heart failure and/or arterial steal syndrczre.
ngioaccess flows of 250-350cc/rain are ideal for
efficient dialysis and result in minimal adverse
caxd,io or 1-rodynamic effects. High flow grafts(greater than 800cc/ruin) are sore likely to
produce high output failure and/or arterial
steal syndrares and these large dianeter(greater than 6. 5mn) grafts stould not he used.
Abstracts 219
PROLACTIN. ZINC AND SEXUAL ACTIVITY IN
DIALYSIS.
Campieri C.,Beui Dardeff A. Borgnino L.C.,
Orsoni U., Stefoni S.
Nephroiogy Dialysis Dent. S. Orsole
University Hospital — Bologna — ITALY
Fifteen uremic males (age 28—45) on
RDT from 11 to 51 months and suffering
from sexual impotence have been investi—
gated with testicular biopsy and serum Te—
stosterone, Prolactin,Zinc and PTH deter—
minations.Hystoiogy revealed alterations
in seminal and interstitial cells.Testo—
sterone values were remarkably low; Prola—
ctin was 3—20 times higher than normal a-id
Zinc (70,2j&g% ml on overage) was constan.-
tly lower than normal; PTH behaved incon-
stantly.Testosterone significantly corre-
lated (p 0.01) with Prolactin and Zinc
alterations.Patients were randomly alloca-
ted in 3 groups of 5 pts each.Group 1 was
treated with Zinc supplementation (4O0,/
1 of dialysate);group 2 with a specific i—
nhibitor of Prolactin secretion (Bromocri—
ptine 5 mg/day) and group 3 with both Zinc
supplementation and Bromocriptine. In all
patients Testosterone and sexual activity
satisfactorily improved. Most striking re—
suits were observed in patients of group
3 treated with Zinc and Bromocriptine.
RENAL OSTEOPAENIA — AN ASSESSMENT OF LONG—TERN
THERAPY WITH VITAMIN D ANALOGUES
G.R.D. Catto, B.J.R. Junor, R.A. Fraser, F.W.
iith, K.V. Ettinger, N. Edward and N. Macleod
Departments of Medicine, Pathology and Medical
Physics, University of Aberdeen, Scotland.
The extent to which therapy with l,25(OH)2D3
or its analogue, l_0(OH)Ds, can reverse progress-
ive renal osteodystrophy is not yet established.
To study this problem, bone disease was assessed
for an average of 5.5 years in 9 patients on
maintenance haemodialysis. The investigative
methods included serial biochemical estimations
of calcium, phosphate, alkaline phosphatase and
parathyroid hormone concentrations, radiographic
skeletal surveys and quantitative bone histology.
Repeated bone mineral analyses and neutron
activation analyses of a hand were also performec
in order to monitor changes in skeletal calcium
content.
Before treatment, progressive osteodystrophy
was demonstrated by all techniques. Following
therapy with a vitamin 0 analogue, all patients
noted symptomatic improvement; serum alkaline
phophtage reyeted to normal 9nd gerun pra—
thyroid hormone concentrations decreased. Radio—
graphically, subperiosteal erosions healed while
the histological features of osteomalacia and
osteitis fibrosa were abolished. Both bone min-
eral and neutron activation analyses indicated
that progressive skeletal demineralis :ion had
been halted. However, a sustained increase in the
mineral content of bone was not demonstrated.
Thus vitamin D therapy, although improving the
biocliemical, radiological and histological feat-
ures of renal osteodystrophy may not restore bone
mass to osteopaenic bone.
ACUTE EFFECTS OF PROPRANOLOL AND IIETOPROLOL ON
PLASMA CONCENTRATIONS OF PARATHYROID HORMONE (PTH)
AND CALCITONIN (CT) IN UREMIC PATIENTS.
B.Coevoet,A.Fournier,H.Andrejak,M.S.Moukhtar,
C.Desplan,C. Calmette,C.Laabrey.
CUU AMIENS, INSERM UI 13 Paris — FRANCE.
Since betablockers are often used in uremic
patients to treat their hypertension.it is iiipor—
tant to know what effect these drugs nay have on
the hormonal control of their already disturbed
calciuai phosphate homeostasis. Therefore ,proprano—
lol (blocking 3l and 2 receptors) was given IV
(priming dose of lmg/5sn+6Opg/ninx8smn) to 9 ureaic
patients not yet on dialysis whereas metoprolol
(blocking only l receptors)was given IV (priming
dose of l.2mgl5mn+72pg/mnx85mn) 15 days later to 6
of these patients.Venous blood samples were taken
before,15,30,60 and 90 ma after starting the in-
jection for measurements of plasma concentrations
of ionized calcium(Ca++) and phosphate(x'04).PTH
and CT were measured with homologous radioimmuno—
assays.There was no significant change at any
time for Ca++ and P04 with either drug.r'TH de-
creased significantly at 30 mn (—367.) with pro—
pranblol but not with metoprolol.CT decreased
also significantly with propranolol at 60 ma
(—40Z) but not with metoprolol. In conclusion
l)propranolol acutely suppresses PTH and CT secre-
tions in uremic patients which warrants further
studies to assess its long term effects on the
secretion of these hormones and on renal osteo—
dystrophy, 2)the contrast between the significant
effect with propranolol and the lack of effect
with metoprolol supports the concept that PTH and
CT secretions are modulated through specific 2
receptors.
ARE CIRCULATING IMMUNE COMPLEXES AND COMPLEMENT
BREAKDOWN PIDUCTS USEFUL FOR THE DETECTION OF
DISEASE ACTIVITY IN NEPHROLOGY?
R.Coppo,F.Giaoohino,F.Quarello,S.Alloatti,G.
Segoloni, A. Vercellone,G,Piccoli.
Nephrology Units,S.Giovanni. Hospital,Turin, (:1.)
In an attempt to evaluate the semeiotic si-
gnificance of circulating imnurie complexes(CIC)
the Ak critically re—examinated the data of 3
years work,even from the point of view of long
term follow—up. 176 patIents (163 bioptically
investigated) with various types of glomerulone
phritis(GN) were studied by means of solid pha-.
se CIq enzyme—linked immunosorbent assay(SP—CIq
ELISA) and polyethylene glyool(PEG) test to do-.
tect CIC. In 45 oases the LA also studied corn—
pleinent(C) factors(C3,C4,CIq,properdifl faotorB)
and C breakdown produots(CBP) C3d and Ba. The
most relevant data were obtsind in patients
with acute post—infectious ON, rapidly progres-
sive GN, acute lupus ON and panarteritis. In
these oases a constant high level of CIC was a
good indication of poor prognosis, whereas de-
creasing values of CIC detected with the SP—CIq
test and increasing data with the PEG test gene
rally indicated a recovery stage. In mesasigioca
pillary ON, Berger's ON and neplirotic syndromes
(minimal changes, focal eclerosing and membra—
nous ON) the CIC data were only rarely of olini
oal relevance. In oases where CIC proved negati.
ve,CBP data sometimes provided the major dete-
ctable immunological sign of disease activity.
220
PATIIOPIIYSIOLOGY OF EXAGGERATED NATRIURESIS (EN)
OF HYPERTENSION.
DalCantonA, Conte G,Fuiano G,Guasco R, Andreucci.
VE. Division of Nephrology, 2nd Faculty of
Medicine, University of Naples, Italy.
7 hypertensivc(I1) and 8 norinotcnsive(N) subjects
were loaded with NaC1 during water diuresis(A) and
in antidiuresis(B). In 4 ant idiuretic patients(2N
and 20) urine volume was raised up to over 30 ml!
mm, by i.v. infusion of hypertonic saline (C). it
is assumed that in (A) C1170 is an index of Na re-
absorption in short Henles loops. In (B) and (C)is proportional to Na reabsorption in long
Henle's loops. In (A) C12o was significantly lower
in H;in (B) Th2o was similar in H and N; in (C)
Tj20 reached a plateau in H, but not in N. These
results show that EN depends on defective reabsor-
ption of Na in Henle's loops,suggesting that the
defect depends on the transmission of hypertensian
to medullary circulation. In fact, C2o in(A), but
not T20 in(B), was reduced in II; the increase in
hcmodynanic pressure in vasa recta would oppose,
indeed, Na reabsorption both in short and in long
loops of Henle;the lattcr,however,belong to non-
autoregulating juxtamedullary nephrons. The effect
on Tfj7Q of the decrease in Na reabsorption in
long Toops is therefore blunted by greater Na de-
livery, secondary to the increase in GFR, that
follows the rise in filtration pressure. The fail
in T20 becomes evident only when the reabsorptive
capacity of Henle's loops is saturated in (C).
USE OF RADIOISOTOPE TECHNIQUE AND PHOTON ABSORP—
TIOMETRY TO DETECT EARLY AVASCULAR NECROSIS (AvN)
S.N. Chatterjee, N. Telfer, and J. vogel
University of California, Davis, California
AVN is quite common in renal transplant re-
cipients. We decided to find out a method where-
by we could diagnose AVN early and thus signifi-
cantly reduce the morbidity. Bone scanning is
usually superior to conventional radiography in
sensitivity. Technetium 99m Suiphacolloid (TcSC)
was used as an index of perfusion, and technetium
99m diphosphanate (tcDP) was used as an index of
osteoblastic activity associated with aseptic
necrosis. We studied 32 patients with TcSC, of
whom 16 had TcDP studies as well. There were 11
patients with AVN with the characteristic pattern
of decreased perfusion and increased bone uptake,
in 5 of whom there was radiologic evidence of
aseptic necrosis. Six others, in spite of having
persistant symptoms, had no radiologic evidence
of AVE.
In an effort to refine the study further, we
have carried out bone densitometry using photon
absorptiometry in another 25 transplant recip-
ients. The result was stored on magnetic tape
prior to being sorted out by a computer. Of 8
patients who developed aseptic necrosis of the
hip, the bone mineral loss was significant in 7.
In the remaining 17, the bone loss was not sig-
nificant. In fact, in most of these patients,
the bone loss ceased following transplantation.
We conclude that these studies provide accurate
and non—invasive techniques of assessing femoral
head circulation and evaluating the changes in
the bone mineral contents in pre— and post—
transplant periods, respectively.
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THE EFFECT OF TRANSPLANTATION ON DIALYSIS
DENENTIA
A H Oavison and C R Giles
Deanrtnmnts of Renal Nedicine and Surgery, St
James's University Hospital, Leeds, UX.
Dialysis dementia is a well recernised syndrome
developing in patients on dialysis and is prob-
ably Sue to aluminium intoxication. In this
Unit 250 patients have received dialysis for more
that 6 months, 140 on home dialysis. 20 cases of'
dialysis dementia have oCcurred, all in patients
on hose dialysis, and 18 of these have died from
complications of the illness, It has been sug-
gested that transplantation may be of definite
benefit in the management of these patients.
Seven of our patients have received a cadaveric
graft. In three patients, symptomatic prior
to transplantation, thex was an exacerbation of
the syndrome with a rapid deterioration to death
in spite of good graft function. In the other
four patients, asymptomatic prior to transplant-
ation, two died from complications of dementia,
one remained with moderate symptoms (psychosis
and dsphasis) but died from a myocardial infar-
ction while the remaining patient developed only
mild symptoms (myocionus and mild dysphasia)
which have slowly regressed over a period of
nine months. The cohcluaion from this study is
that transplantation causes a deterioration in
the symptoms ofdementia in spite of a restor-
ation of satisfmctciry renal function and thus
should not be used in the managernt of this
distressing condition.
ARTERIOVENOUS FISTULA BLOOD FLOW IN CHRONIC
HAEMODIALYZED PA1IrNTMPARISN0FVA[1JES
OBTAINED BY THE DYE-DIL1JTTN METHOD AND BY THE
8. DONGRADI, P. ROCHA, d.C. KAHN, B. BARON,
lMAItHEZ, J.P. FENDLER (Intr. by J.M. IDATTE).
C.H.U. Paris-Ouest, HOpital de Poissy, FRANCE.
Blood flow in the arteriovenous fistula (AVF) of
9 chronic haemodialyzed patients was quantitated
by the injection of dye into the afferent artery
of the AVE and measurement of the dye concentra-
tion in the efferent vein of the AVF ; if the AVE
is supplied by both the proximal and distal seg-
ments of the afferent artery, the flow measured
is exactly that of the AVF ; if the AVE is sup-
plied only by the proximal segment of the affe—
rent artery, the flow measured exceeds that of
the AVE by a quantity equal to the flow in the
distal arterial segment, a quantity which is
generally very small in relation to the flow
through the A1E. AVE blood flow measured by dye-
dilution (AVE BE) was between 0.5 and 5.4 1/mn
(mean 2.0 1/mn). The change in cardiac output
(CO) following temporary occlusion of the AVE
in the same patients was between -0.4 and 2.6
1/mn (mean 0.8 1/mn). In each patient AVE BE
was greater thanCO ; the correlation between
AVF BE andCO was significant (p (0.01) but the
linear regression of AVF BE overACO did not
allow accurate prediction of the AVE BE from the
4C0 in a given patient. We conclude the true
AVE blood flow in CHP is considerably greater
on average than that estimated by the change in
cardiac output following temporary occlusion
of the AVE
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DONOR SPECIFIC SUPPRESSOR CELLS IN HUMAN RENAL
ALLOCRAFTS.
7.8. Dossetor, E.M. Liburd, T. Kovithavongs, M.R.
Higgins, V. Pszderks.
University nf Alberts, Edmonton, Alberts, Csnsds.
The low requirement for immunosuppressive medi—
cstion sfter the first few months in successfully
transplanted renal allograft recipients suggests
that donor (D) specific immunologic "tolerance"
may have been induced. We have sought evidence of
this by 2 in vitro parameters in sequential post—
transplant sampling of recipient (R) patients'
peripheral blood lymphocytes (PBL): a) changes in
the capacity of mitonycin treated D cells (Dm) to
generate cytotoxic lymphocytes (CTL) in R cells,
in a 6 day mixed leukocyte culture when then test-
ed in cell mediated lympholyaia (MLC-*CML) assay
against D target cells; and b) suppression of CTL
generation by Dm in third party normal cells (X,
Y, or Z) when small numbers of Rm cells are added
to 6 day NCL when then tested in CML against D
target cells. Cell proportions in [x/Dm + Rjcul—
ture are 1:1.25 : 0.25. These two [eats were dea—
igned to pick up donor—specific reduction of R
responsiveness and donor—specific suppressor cells
(EL) in LPBL.
Clear evidence of EL was obtained in all pat-
ients (5 CD and 3 LD) studied so far. EL appeared
within 3 weeka and remained thereafter. No major
rejections occurred in these 8 so we cannot say
if EL, and donor specific R unresponsiveness, die-'
appear before rejection though these aspects are
under study. This suppression by R.P8L is mediated
by the T cell aubpopulation. EL develop in HLA—
identical sibling recipients after transplant so
HLA differences are not responsible for generat-
ion of EL, in these.
ANGIOCARDIOGEAPHIC AND HAEHODYNAMIC STUDIES IN
CHRONIC HAEMODIALYSIS (CH) PATIENTS (pta) WITH
CARDIOMEGALY. T. DrOeke, C. Le Pailleur, N. Sigal-
Saglier, 7. Zingraff. Clinigue Ndphrologique and
Clinique Cardiologique, HSp.Necker,Paris, France.
Growing interest haa been devoted in recent years
to cardiac involvement in uraemic pta. In the pre-
sent work we used the technique of angiocardiogra-
phy and haemodynamic studies to explore cardiac
function and contractility in CH patients with
cardiomegal. Twenty—one CH pte were selected for
left ventricular cineangiography on the basis of
cardiac enlargement and repeated episodes of heart
failure and/or angina. Clinically, 5 pta presented
with angina, 3 with valvular heart disease, and IS
with heart failure. Five pta had longstanding ar-
terial hypertension, and 2 chronic fluid volume
overload. Cardiac index was increaaed in 7 pta,
normal in 9, and decreased in 1. Left ventricular
end—diastolic (LVED) volume was augmented (> 100
ml/m2) in 11/21, and LVED pressure (>12 mnHg) in
14/21 pta. Myocardial wall thickness was increas-
ed (>12mm) in 11/21 pta amd normal in 10/21.
Ejection fraction was < 0.50 in 9/21 pta. Maximum
velocity of myocardial fibre shortening was de-
creased in 15/21 pta. Pericardial effusion was
found in 1/21 pta, and coronary heart disease in
only 3 out 16 pta who had coronarography.
In conclusion: An important number of our CH pta
with cardiomegaly had diminished cardiac perfor-
mance in the absence of demonstrable coronary
heart disease, hypertension or chronic volume
overload. The diagnosis of congestive cardiomyo—
pathy of unknown etiology, possibly related to
ursemia, was reached in 10/21 pta with cardiac
enlargement.
THE LEWIS ANTIGEN SYSTEM AND ITS RELEVANCE
FOR CLINICAL TRANSPLANTATION
Elisabeth Fischer, V. Lenhard, W. Rbmer, K. Drei-
kern, K. SchSrer, 0. Roelcke.
Institute of Immunology, Department of Urology
and Children's Hospital, Heidelberg, IV. Germany.
The objective of the prescnt study was to examine
the influence of the l_ewis blond group system on
transplant prognosis. We analysed retrospectively 173
kidney transplantations. The recipients were classified
according to the different l_ewis phenotypes: Le(a-b-m-),
Le(ai-b-), Le(a-b-). Actuarial survival rates were compu-
ted by the method described by Merrell and Shulman,
statistical significances calculated by the log-rank test.
One year graft survival in the total group was 72%.
In the Le(a-b÷) recipients one year graft survival was
significantly superior to the Le(a+b-) recipients (80%
vs. 53%; pc 0.005) and highly significant better than in
the combined group of Le(a+b-) and Le(a-b-) recipients
(80% vs. 53% and 64%; pc 0.001). By calculating from
the known distribution of the Lewis antigens in the
Eurnpean population (Le(a-b÷): about 65%; Le(a+b-): 25%;
Le(a-b-): 10%) incompatibility in the Lewis system would
be expected in about 90% of the Le(a-b-) and in 75% of
the Le(a÷b-) recipients. These two groups in fact had
significantly lower graft survival rates than the Le
(a-b÷) recipients of whom only 35% should be Lewis-
incompatible. HLA incompatibility index, schemic
time of the transplants and the percentage of patients
transfused before transplantation did not differ statis-
tically in any of the three groups. Our findings suggest
again the relevance of the Lewis blood group system
for clinical transplantation.
ADVANTAGES OF CAPD TO THE DIABETIC WITH RENAL
FAILURE.
C.T. Flynn, 7. Hibbard, B. Dohrman.
Iowa Lutheran Hospital, Des Moines U.S.A.
We have treated 30 diabetic patients with
chronic renal failure. Blood pressure and blood
sugar control was poor and vascular disease
progressive. Intermittent peritoneal dialysis
(PD) did not improve these problems compared to
Hemodialysis (HD). Therefore a trial of contin-
uous ambulatory peritoneal dialysis (CAPD) was
undertaken.
Tenckhoff silastic peritoneal catheters were
used. Each exchange was of 4.25k dextrose PD
solution at 8 h intervals. Insulin was added to
each PD solution and was not given by injection.
Self-care was taught from the start, using the
spouse if visual problems were present.
Peritonitis occurred in some patients but did
not stop CAPD or require admission to hospital.
Serum creatinine levels fell and Hb levels rose.
Blood pressure levels fell to normal without
drugs or restriction of salt intake. Fasting
blood sugar levels were usually normal and most
post-prandial levels were 100-150 mgm/dl.
Patients who had been anticipating HD required
such experience to help them decide on CAPD. The
time occupied by procedures was Greater with CAPD
than ND. The repetitive routine of CAPD had a
demoralizing effect on helper spouses. Self—care
was achieved even when visual problems were pres-
ent and seemed necessary for successful CAPD.
The advantages of CAPD to the diabetic with
renal failure are greatly improved control of
blood sugar and blood pressure and, potentially,
diminished progression of vascular disease.
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ADVERSE EFFECT OF VITAMIN U MLTA8OLITES ON OSTEI-
TIS FIBROSA IN PATIENTS ON CHRONIC HENODIALYSIS
CRiTiCAL ROLE OF INDUCED HYPERPHOSPI-IATEHIA.
JE de Fremont,B.Coevoet,JL Seberr,J.Gudris,
G.Lambrey, P .Narie ,P.Meunier,A. Fournier.
CDII Amiens,II6pital LariboisiBre ?aris,Universitd
Claude Bernard Lynn.
An associition of l'XOH—vitamin 03 and 25—DR
vitamin D3 was given to 19 patients on chronic
heniodialysis for 12 months.lnitial daily do. os
were respectively 1 and 50 pg but in 17 patients,
to correct hyperca lcemia and hyperphosplia temia,
the treatment was repeatedly discountinued and
then resumed at half doses.The patients,already
on dialysis for 32÷6 months ,were dialyzed 3 times
4 hours a week against a dialysate calcium of 7.0
mg/dl and were taking an oral calcium supplement
of l.2g and variable doses of A1(OH)3.Squeletal
Xrays and histosorphometrical evaluation of iliac
bone biopsies were performed before and 6 and 12
months after vitamin U treatment.Before treatment
no patient had osteomalacia but 13 had increased
active resorption surface.At the end of the study
no change was observed in 7 patients,but bone re-
sorption increased in 6 and decreased in 6 others
Histological worsening of hyperparathyroidism was
associated with an increase in plasma concentra-
tions of phosphate(p(.05)and parathyroid hormone
(p<.Dl)in spite of higher "prescribed' doses of
Al(OH)2 and similar changes in plasma concentra.
tions of 25 OIl D.It is concluded that l)basic
treatment of dialysis osteodystrophy prevents ade-
quately osteomsiacis but not hyperpsrsthyroidism,
2)addition of vitamin U metabolites to this treat-
ment may be either beneficial or noxious accor-
ding to wether the induced hyperphosphatemia is
or isn't adequately prevented.
ANn—lILA 1MMiJNISAT1DN IN 130 HENODIALYSED PA-
TIENTS.
J. GAULTIER, N. OLSEN, P. MERCIER, N. RAMPAL.
Service do Ndphrologie. N8pital do la Conception
Marseille, France.
Anti—HLA iemunieation have been studied in
130 patients treated by heeodialysim between
1969 and 1978. Up to the year 1977 the blood
transfusions were roatricted (number of irene—
fusions per patient averaged 3,42 units). Howe-
ver 50 % rf the patients were found to be imsu—
niaed. The frequency of iemunisetion is higher
in woeen patients (63 %) than in men (39,7 %).
This difference is in good correlation with the
frequency of pregnancies (r = 0,849). The per-
centage of ismunisation increases on sympathy
with the number of months of dialysis (r =
0,975). The capacity to eliminate the Ag Hbs
seems to be related to the capacity of anti—HLA
iseuniaation 64 % of the patients with a tran
aitory aniigenicity Hbs develop antibodies
anti—HLA and ooly 26,7 % when antigenicity is
persistent.
Since i977, 24 patients were transfused with
2 units of blood once a week for 3 weeks every
Sosemthm._Antibodies appeared in-only 5 of them
who had been transfused some years ago. HLA sys-
tem and transplantation play a esall part. The
age, the type of nephropathy seem to have no
action. Few patients developed antibodies
without any apparent reason. Perhaps bacteriolo-
gical or viral infections or veinoua allografte
may be responaable. So in dialysed patients who
had hardly any tranefusion, the pregnancies,
the longevity of the dialysis and the reactivi-
ty of the Ag Hbs seem to play an important role
in the developeent of the antibodies anti—HLA.
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GLUCOSE TOLERANCE IN PATIENTS ON HEMODIALYSIS(ND),
SEQUENTIAL ULTRAFILTRATION + DIALYSIS (UFD) AND
NEMOFILTRATION (HF).
R. Geronasus, B.von Albertini, S. Glahsan, T.Kahn,
E. Rayfield and J.P. Bosch (intr. by N. Naimov),
Mount Sinai School of Medicine, New York, N.Y.USA
It has been shown that the impaired glucose
tolerance of uremia improves with ND in associa-
tion with higher insulin levels. We have studied
glucose tolerance in patients undergoing two new
treatment modalities for ESRD: Intravenous glu-
cose tolerance tests (GTT) were performed in S
patients st the end of a 5 months control period
on ND and after 4 months on UFD. The ssme studies
were done in 6 patients at the end of 5 months
control ND and after 4 months on NF. ND and UFD
were performed with a Travenol CF 1500 hollow
fiber dialyzer and HF with an Amicon Diafilter 40
(l.3m2). All treatments were done 3x weekly and
adjusted to maintsin the same pretreatment BUN of
9Omg/dl. GTT was performed pretreatment after an
overnight fast; 0.5gm/kg glucose wss given intra-
venously and samples for plasms glucose and insu—
un were obtained at 10 minutes intervals.
While 9lucose tolerance and insulin gesponse
were similar in IJFD and ND, the following changes
were observed in NF:
Insulin (pU/ml) Glucose (mg/ml)
(nat) 0' 10' 20' 30' 60' 0' 10' 20' 30' 60'
ND 14 91 76 63 38 97 303 246 209 131
NP 13 69* 56* 46* 30 96 294 239 202 140
(*p<.05 by paired t, ND vs. MF)
During GTT lower insulin levels were found in
HF than ND in association with no change in glu-
cose tolerance. These data suggest that NF may
alter carbohydrate metabolism in uremic patients
differently than ND.
TIlE MTGPATTCN OF PLASTICIZERS FRCI4 PVC HENODIA-
LVSIS TUBES.
J.Cerstoft, E. christianeen, T.L. Nielsen and
B. Nielsen.
Dept. at Nephrolegy, Copenhagen City Hospital,
Hvidevro, Denmark.
Am plosticizers released from PVC hosoiialy—
mis tuham are lusown to he potentially toxic, an
investigation of the amount of plosticizer re-
leased during dialysis was performed.
Tn 4o in vitro plamsa porfusieos for 8 hours
the amount of plasticizer released was determi-
ned by gas chromatography.
The only plasticizer released was di-2—etbyl—
hexyl phthelete. (DEHP)
11 different coersercially available tubas ware
compared. The migration of DEER was found to he
lineary with tine and indepeedent of roncentra—
tion. The armount of DEER released during the 6
hours assay peried varied hatwoen 2,8 and 4,e
ou/hour (mean 3,4 mg/hour) iedicating an uptake
of 16 oq during a 6 hours dialysis.
Sterilisation by irradiation, othylen oxide
and formaldehyde did not sigoifirantly change
the onsount of DEER releamed.
'Reuse' after storing in fonaaldehlkle was
found to reduce the DEHP release significantly.Test tubas coated with pnlyurethari ware also
examined. The coating showed no significant inspect
upon the release of DEHP.
Tt is concluded that further toxicologic eta-diem on DEER are mandatory, as are investigations
on the possible elizeieation of DEIIP release from
PVC during henrrlialysis.
No significant differencem hetwoon neither the
tubings, nor the aterilisation procedures used
wore found.
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ALUMINUM,EEG AND INTELLECTUAL FUNCTION IN
PATIENTS ON REGULAR DIALYSIS TREATMENT
(ROT).
Gilli P.,De Bastiani P.L.,Fagioli F.,Rosa
ti G.,Betti A. ,Farinelli A.—Servizio di
Nefrologia,Clinica Neurologica,Istituto
Chimico , Ferrara , Italia.
Our program concern:A)determination of Al
concentration by flameless atomic absor-
ption in;1)tap water;b)water purified by
demineralizing;c)dialysates prepared by
single automatic units;d)serum of 44 nor-
mal subjects without Al (OH)3;e) serum of
69 patients on ROT taking Al(OH)3;B)neuro
logical investigation(18—30 hours after
the last treatment)with EEG and a battery
of psychological tests(WAIS,Corsi's Block,-
tapping task)in:a) 11 patients on RDT and
Al (OH)3 for 6-54 months with normal se-
rum Al levels(SAL);b)ll patients on RDT
and Al(OH)3 for 6-96 months with increa-
sed SAL. Our data can be summarized as
follows:])SAL is higher (P O,O1)in patien
ts on ROT than in norisal subjects;2)SAL
is higher(P=O,06)in uremic on ROT and Al
(O-I)3 for a period longer than 6 months,
without correlation between SAL and time
of dialysis and Al(OH)3;3)EEG and psyco-
logical teats did not differ in uremic
with various SAL.
RDT WITH ACETATE—FREE BICARBONATE BUFFERED DIA
LYSIS FLUID: LONG—TERN EFFECTS ON LIPID PATTE-
RN, ACID-BASE BALANCE AND OXYGEN DELIVERY.
G. Giorcelli, F. Dalmasso, N. Bruno, S.Pelle—
grino, N. Sirkka, 0. Vacha.
Ospedale Nauriziano, Torino, Italy.
Twelve patients affect of CHronic renal fa-
ilure with type IV hyperlipidaemia, under regs
lar dialysis treatment (RDT), have been stucli—
ed. for 9 months. Plasma trygliceride levels
has diminished in 9 patients wen bicarbonate
was substituted for acetate in dialysis fluid
(from 273+95 mg% to 122±56 mg% after 8 months)
In these patients it can also be noted a very
good tolerance to treatment, a quicker correc-
tion of acid base balance, no significant van
ations in 2—3 DPG levels and intraerytnrocyta—
ry pH, compared to standard haemodialysis with
acetate as a buffer. After return to standard
dialysis tniglydenide levels goes up to values
higher than those found at the beginning of
treatment with bicarbonate buffered dialysis
fluid (305±69 mg%).
PRODUCTION OF A NATRIURETIC HORMONE
BY ISOLATED RAT KIDNEYS:NECESSITY OF
PROSTAGLANDINS FOR ITS RELEASE.
J. P. Godon and P. Carnbier.
Université, Inst. de Médecine, Liege, Belgique.
We have demonstrated that the origin of a na-
triuretic factor(N. F. )was renal. We studied the
action of this N.F. in a cell free perfused rat
kidney and the effect of prostaglandins(Pg)on its
action or production. The N.F. was prepared
from normal salt loaded rats and tested onisola
ted rat kidneys. These kidneys were taken either
from normal rats either from rats previously
treated by indomethacin. The mean rise of frac-
tional sodium excretion(FE Na)was siilar in
both sries after N.F.injection:+6.0l-2. 14 and
+4. 09 -0. 85 respectively(P)O. 1). In the presence
of the N. F. solvent alone, the rise in FE Na was
only +0. 21. The ability of isolated rat kidneys to
produce the N. F. was studied in two series of
salt deprived rats. One serie was injected by in-
domethacin prior to nephrettomy. In both series,
we collected samples during the perfusion in or-
der to test the natriuretic activity of the perfusa.
te before and after a saline load. Before the salt
load,theN.F. was undetectable in both series;
after the salt load, the N. F. was absent in the
perfusate of kidnys prepared by indomethacin( FE Na:+0. 81- 0.4) and present in the perfu-
sate of normal kidneys(FE Na+7-2. 35). Through
these experiments, we demonstrate that the N. F
do not need plasma factors for its action:it is a
true intrarenal factor; it does not need Pg to be
active but the presence of Pgis quite necessary
for its release or synthesis.
THE USE OF COMPUTER GRAPHICS IN A MAINTENANCE
HAEMODIALYSIS UNIT
M. Gordon, H.E. de Wardener, P.E. Gower,
J87€i
Charing Cross Medical School, London, England.
Maintenance haenodiaiysis and transplantation
require accurate interpretation of large quanti-
ties of clinical data. This becomes unmanace-
able and obscure as the number of patients
increases, and there are changes in medical and
nursing staff. Computer methods were previously
expensive, but the recent revolution in elec-
tronics has reduced equipment costs almost ten-
fold. Programming costs can be reduced by copy-
ing successful prototypes. A prototype system
for a Renal Unit is described, based on PDP-1l
computers, which has been in service for two
years and allowed development of simple, sensi-
tive responsive data retrieval. Standard video
monitors present graphs which elucidate trends
and correlations. Pathology data acquired
directly frorp laboratory computers are scanned
for abnormality. Programs have been trans-
ferred to an [SI-li microcomputer to provide
a flexible low'cost package. Medical
and Nursing staff use the system routinely
without computer staff present, and have found
it valuable in looking after patients. Insidious
trends in blood pressure, weight and certain
biochemical abnormalities have been detected
through its use.
The conclusion is that cost-effective
information technology is now available for data
intensive specialities such as maintenance
haemodialysis centres.
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NEUROPATHY AND SHORT TIME HEMODIALYSIS (STH)
U.Graefe,O.Knol 1 ,D.Steinhausen,G.Al terhoff,H.Loew
MiTiische Poliklinik und Rechenzentrum,Uni—
versitt MUnster,FRG.
In a prospective study we investigated the in-
fluence of small (SM) and middle molecule (MM)
levels on the wellbeing of 45 patients on STH.The
mean follow up period was 2Omonths,the mean resi-
dual Gfr 0.2 ml/min (0-0.9 ml/min).Laboratory and
clinical data,motor nerve conduction velocity (MN
CV) and vibration sensitivity (VS) were con-
tolled every 4-6 weeks.Patients were separated
into 4 groups depending on the calculation of the
Dialysis Index (D1) which is based on a 30 1 MM-
clearance/week which is supposed to be necessary
to maintain patients wellbeing.The mean results
for hematocrit (HK).creatine (Cr) and SUN in the
four groups were:
A(n=14) B(n=1O) C(n=11) D(n=1O)
D 0.6-0.8 0.8-1.0 1.0-1.2 above 1.2
(vol%) 34.1 25.1 26.0 23.9
Cr mg% 16.9 15.5 15.5 13.5
SUN mg% 97.5 91.5 81.4 80.2
No patient developed significant changes in MNCV
or VS which were within the normal range through-
out the study.This is in contrast to earlier re-
ports where a DTbelow 1.0 resulted in a signifi-
cant decrease in MNCV.Though SM levels were high-
est in group A the HK in this group has not been
influenced negatively.From our study we conclude
that significantly less than 30 1 MM clearance!
week might be sufficient to prevent neuropathy in
well nourished patients and that rather high SM
levels might be accepted without disadvantage for
the patient,To enhance ultrafiltration tolerance
during STH recirculation of dialysate or I-1C03-
containing dialysate might be indicated.
HANDLING OF PHOSPHATE BY THE TRANSPLANTED KIDNEY
H.Graf, J.Kovarik, H.K.Stumrnvoll, A.Wolf,
W. P nggera
2 Med.Dept. University Vienna (Austria)
The handl ing of phosphate(P.) by the transplan-
ted kidney was studied in 1+1 renal allogralt re-
cipients with good and stable transplant function
(serum creatinine(Cr)&2,O eg/lOOmI, graft survi-
val 12 months). Ca, P, Cr was measured in serum
and urine, phosphate threshold (TmPO/GFR) was
calculated using Bijvoet's nonogram; IPTH was de-
termined using an antibody against the C—regional
part of the PTH aclecule.
Only 8 pts showed normal renal P handl irig as
indicated by normal serum P., TmPO/GFR and nor-
mal iPTH. All other pts (33) had a decreased
TmPO/GFR. This P. leak was due to persistent
hyperparathyreoidism in 11+ pts, of them showing
additionally hypophosphatemia and hypercalcemie.
In the remaining 19 pts there was a PlHindepen—
dent P.leak as indicated by decreased TmPO5/GFR
despite normal IPTH values. In this group pts
had a decompensated P leak leading to hypophos—
phatemi a.
Even alter successful kidney transplantation
with longterm surviving good and stable functio-
ning transplants a high percentage of pts shows
abnormal renal P handling. To prevent osteomala—
cia and other symptoms of the phosphate depletion
syndrome means should be undertaken to lower PTH
levels in the pts with the PTH dependent leak
(Vit D analogues, PT ektomie)whereas sufficient
P. supplementation (oral P or also Vit D) is
necessary in pta with PTH independent decompcnsa-
ted P leak.
MISSING HORMONAL RESPONSE TO VOLUME
DEPLETION IN URAEMIC PATIENTS ON REGULAR
HEMODIALYSIS.
M.Hammer, S. Dawids, M. Bredgaard,
0. Christensen and K. Med. Dept.
P, Aneath. Dept., Surg. Dept. D and Dept.
Clin. Chem., Rigshospitalet, Copenhagen,
Denmark.
Weight reduction in hemodialysis pati-
ents during hemodialysis is often compli-
cated by sovore hypotension and bradycar—
dia. To evaluate the hormonal response,
7 non—nephrectomized patients on regular
hemodialysis, were investigated during
2 hours pure ultrafiltration at start of
the dialysis. Pressures in the central
circulation and cardiac output were mo-
nitored by a Swan—GanzR catheter. Plasma
samples were obtained every 15 mm. and
analysed for vasopressmn, catecholamines,
cortisol, renin and aldosterone.
While a good response to decrements in
central pressures was found in the renin—
aldosterone system no increments were ob-
served in neither noradrenalin nor adre-
nalin despite high basal levels and de-
spite decrements in both cardiac output
and arterial blood pressures. Increments
in vasopressin conc. were observed only
concomitant to decrements in arterial
blood pressure. The present study indi-
cate that uraemic patients are missing
the sympathetic cardio—vascular response
and tte volume response in vasopressin
while the renin system seems to function
independent of the two other systems.
NORMALIZATION OF GLYCEMIA,GROWTH HORMONE HYPERSE-
CRETION AND HYPERGLUCAG0NEMIA IN UREMIC LONG-TERM
DIABETICS.STUDIES WITH ARTIFICIAL KIDNEY AND AR-
TIFICIAL PANCREAS.
Aa.P.Hansen,H.E.Hansen,H.Ørskov,R.Nosadrinj and
G.Noy.Aarhus ,Denmark and Newcastle,England.
Hemodialysis treatment in diabetic patients
with uremia is characterized by severe fluctua-
tions in blood sugar levels.5 uremic diabetics
in long -term treatment with hemodialysis were
studied with hourly blood samples during a
24-hr period including 5—7 hr hemodialysis againsli
glucose free dialysate.17 experiments were perfor-'
med,8 of them with an artificial beta cell (Bio—
stator).In each case the artificial pancreas was
able within 1 hr to adjust blood glucose to 150
mg/l0O ml,and to keep it within a range af 10
mg/100 ml throughout dialysis.The high and fluc-
tuating plasma growth hormone that is characte-
ristic for diabetic patients was completely
suppressed in 16 of 17 experiments within hr
after start of hemodialysis and it did not recur
until 3 hr after cessation of dialysis.The same
pattern although less clear cut was observed for
glucagon.Theee findings may point to a dialysable
factor being responsible for the hormonal hyper—
secretion in diabetes and uremia.Results have
excluded FFA,betahydroxy-butyrate ,alanine ,lactate,
pyrovate,glycerol.Currently other candidates and
non-diabetic uremics are being studied.The diffi-
cult problems in controlling electrolyte and
metabolic aberrations during and after dialysis
so often encountered i uremic diabetics were in
practice abolished when the artificial pancreas
was utilized.
JCIDNEY GRAFT SURVIVAL, CLINICAL COURSE, BLOOD—
TRANSFUSIONS, HLA(-A+-B) MATCH, INDIRECT D AND DR
MATCHING, IN 277 ADULT PATIENTS TRANSPLANTED IN
DNE CENTRE.
LJ.PvNooff, A.van Es, G.G.Persijn, Y.E.A.van Ilooff-
ykenboom, M.W.Kalff, J.J.van Rood and J.de Graeff
Departmentaof Nephrology and Immunohematology,
University Hospital, Leiden, The Netherlands.
The data of 277 cadaveric kidney grafts were
analysed within 6 months after transplantation.
20 non—transfused patients had a much lower graft
survival than the 257 transfused patients (25%
versus 69%; p< 0.001). 36 patients with more than
20 transfusions showed a graft survival of 75%.
The non—transfused patients were not included in
gurther analysis. Graft survival was correlated
with the NLA(—A+—B) match',Full House identhal 86%
(n=29); 0 mismatch 82% (n=39); 1 mismatch 69%
(n112) 2 mismatches 52% (n=77)*. Excluding non—
immunological failures: only 10% of 63 transfu-
sed patients without a mismatch had a graft failu-
re due to immunological reasons. In 188 patients
with a graft survival of 6 months no correlction
was found between HLA-A+-B, A or B match with
either the number of rejection crises or with the
level of serum creatinine. However, patients iden-
tical for HLA—B7 or —B8 with a higha with certain
lILA D antigens (and also with other loci in the
flLA region) had less reversible rejection episo—
es than patients with a lowera (pO.O3) . Graft
Survival correlated with the degree of the DR
zaatch: 0 mismatch 80% (n10) ; 1 mismatch 71% (n
4); 2 mismatches 65% (nl7) . (Non—immunological
ailures were excluded).
*p<o. 001.
PLASMA EXCHANGE (PS) 1N IMNUNE COMPLEX DISEASE,
D.A. Houwert*, L. Kater*, R.J. Hene**, A.Struyven-
herg*, Depts of mt. Nedicine* and Nephrol.**,
University Hospital, Utrecht, The Netherlands.
PS can have a favourable effect in immune com-
plex disease in which removal of circulating
immune complexes (CIC) appears to play a critical
role. We studied the relation between removal of
CIC by PS and clinical course of the disease in B
pts with acute SLE and 2 pts with rapidly progres-
sive glomerulonephritis (RPGN) . CIC were measured
by at least 3 of the following tests: indirect
granulocyte phagocytosis test; Raji—celltest; Clg
and conglutinin binding assays; and presence of
mixed cryoglobulins. In the acute phase PS was
carried out 3 times a week; in each session 1.5
liter of plasma was replaced. PE was carried out
as sole therapy, or current therapy was kept con-
stant for at least 14 days before PS. Five pts with
SLE and both pts with RPGN had nephrotic syndrome
(MS) . One of the latter group had Henoch-Schiinlein
the other essential mixed cryoglobulinaemia.
Evidence of CIC in 2 or more tests was found in
6 of B pts with StE and in 1 test in both RPGHpts.
Four of the 6 pts with CIC and SLE and both pts
with RPGN improved on PF. HS and CIC disappesrod.
In 1 of the remaining 2 pta with CIC complement
factors rose to normal, but kidney function dete-
riorated, the other did not improve. Two pta had
no detectable CIC and showed no improvement on PE.
The results suggest that PS is almost invariably
effective in pta with detectable dC. Negative
tests for CIC detection do not exclude the
presence of CIC. Therefore PS should not be with-
held from pts without detectable CIC. One should
rely on at least 2 and preferably more teat
methods.
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MARKED POSTPRANDIAJ. INCREASE IN SERUM CUNLtr,iRA-
TION AFTER MEALS CONTAINING COOKED MEAT.
F.K.Jacobsen, C.K. Christensen, C.E.Nogensen,
F. Andreasen, N.S.C.Heilskov (Intr. by H. E.
Hansen)
Nedical Department I, Aarhus Amtssygehus, Aarhus,
Denmark.
To clarify the effect of ingestion of meals
containing cooked meat on serum creatinine con-
centration, 6 young men were served a meal of
Soo g of goulash containing 25o—3oo g of beef.
Serum creainine rose from a mean prevalue of
86 umol/l —lO.2 (SD) to a maximal mean value of
175 umol/l — 11.9 (SD) three hours after start of
the meal and then decreased gradually and twenty
hours after ingestion it was still significantly
higher than before the meal. No change in creati—
nine clearance was observed. Only minimal effect
on serum creatinine was noted after a meal
without meat. Ingestion of 300 g of raw beef did
ot influence 'serum creatinie at all (88.5 umol/j
— 9.9 (SD)—) 88.5 umol/l— 9.1 (SD)). Ingestioa
of 300 g of boiled beef increasd the serum cre—
atinine level÷from 86.7 umol/l — 10.8 (SD) to
162.8 umol/l — 17.9 (SD), whereas ingestion of
300 g of fried beef exhibited less pronounced
postprdndia increase in serum creatinie(84 umol/l — 13.8 (SD)——--—) 110 umol/l — 14.0
(SD)). Creatinine determination in serum by
conventionel Auto Analyzer (R) method and an
ion exchange method gave practically identical
results.
It is concluded that ingestion of cooked meat
causes a poatprandial rise in aerum creatinine
and urinary excretion of cteatinine. Creatinine
is produced from creatine in meat during the
cooking procedure.
REMDV))L OF DREMIC TOXINS BY HENOFILTRATION WITH
DIFFERENT MEMBRANES. THE BENEFIT OF REGENERATING
HEMOFILTRATE USING A NEW DEVELOPED SYSTEM.
S.JØrstad, L.Smeby, T.E.Widerge, K.J.Berg.
The Department of Nephrology, Trondheim, Norway.
Based on earlier findings indicating that uremic
toxins inhibiting human mononuclear phagocytes
cultured in vitro are of mol.wt.larger than 10000
a new system, SEDUFARK(selective dual filtration
artificial kidney) was developed: I = open filter
CC = Collecting containeP
in which large mole-
cules were retained
• II A less open filterI cc fl 0 = Dialyzer (low flow)
The primary hemofiltrate(HF1) was pumped into a
CC from which the filtrate was recirculated thro=
ugh filter II. The hemofiltrate from filter II
was dialysed by means of low flow dialysis in 0
and finally returned to the patient.The effect of
uremic plasma drawn pre and poat SEDUFARK treat-
ment(SED) and used aa culture media on the cell
model were compared with uremic plasma pre and p0—
at conventional hemofiltration with cuprophan(CPN)
and polyacrylonitrile membranem (PAN).
kesults given in per cent of control(normal aerum)
Trea Cell Phagocytosia of'I—label—
Bent n detachment led Candida albicans
Pre Post Pre Post
CPN 6 3,1+0,3 0,1+1,9 37,8±3,2 60,5±7,7
PAN 6 4,0+1,8 32,3+9,6 46,5±8,7 72,4±9,6
gED 6 3,8±0,8 37,2±9,8 S8,7jll,0 96,0±4,3
Ra shown in the table the results after SED was
better as compared with CPN or PAN treatment.With
the SEDUFARK system any mol.wt.substances depend-
ing on the membranes in I and II can be removed
from uremic plasma returning essential substances
at tht same tise
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PERITONEAL DIALYSIS (PD) IN KETOSIS-
SUSCEPTIBLE DIABETES MELLITUS (KDM)
C.Kablitz, R.L.Stephen, D.P.Duffy, W.J.Kolff
University of Utah, Salt Lake City, Utah, USA.
Thirty-two patients (pts) classified as KDM en-
tered our chronic PD program between July 1976 and
December 1978. All had diabetic nephropathy, their
diabetes had been diagnosed before the age of 30
years. Mean age was 33.4±7.0 years, mean serum cre-
atinine 11.4±3.8 mg/lOOml at onset of PD treatment
Five more PD-pts with uncomplicated AODM (mean age
53.2±11.2 years) were not included in this study.
Ten pts (31.3%) were blind in one or both eyes,all
had impaired vision when PD commenced. Visual acu-
ity deteriorated in 5 pts, remained unchanged in
26 pts, and improved in 1 pt. Total time at risk
was 43.4 pt years, time survived 22.9 pt years,ti—
me on PD 13.6 pt years [21 pts received 25 kidney
transplants for a total functioning time of 8.5 pt
years (mean 124 days), S pts are surviving with
functioning grafts]. Overall cumulative survival
at 3;6;l2; and 18 months was 82%; 71%; 60%;and 54%
For PD alone cumulative survival was 77%(3 months),
70%(6 months),and 57%(12 months).Sixteen pts (50%)
died (7 deaths/l000 pt weeks). Causes of death we-
re: cardiovascular 11(68.8%), sepsis 1, withdrawal
from therapy 2, other 2.
PD was relatively free from complications and
was tolerated well. Manual and reciprocating PD
were used predominantly (18—20 hrs/week),2 pts we-
re on CAPD. Peritonitis frequency was 1/47.5 pt
weeks, 2 pts required occasional additional (hemo)
ultrafiltration to control excessive fluid over-
load.
PD seems to cause less associated morbidity in
these pts than that reported for haemodialysis
while survival rates are similar.
THE VITAMIN D'S IN CHRONIC RENAL FAILURE
JA Kanis, RGG Russell, CM Taylor, T Cundy,
M Earnshaw, G Heynen (Intr 0 0 Oliver)
Renal Unit, Churchill Hospital, Oxford, UK
We have investigated the relationships bet—
ieenbone disease and disturbed vitamin 0 cotabol—
Lsm in patients with advanced chronic renal
failure. Several observations suggest that the
importance of defective production of 1,25—
dihydroxyvitamin D3 (1,25(OH)2D3) in the aetiology
of renal bone disease has been over estimated.
Thus not all patients, even after nephrectomy (20
studies) , develop bone disease and not all
patients with bone disease respond favourably to
1,25(0H)2D3 or 100HD3 (25 studies). We cannot
support recent claims for the role of 250HD3,
since plasma levels were normal in our patients
(60 studies) and the results of treatment with
250Ho3 no different from the use of 1,25(OH)2D
On the other hand, 24,25(OH)2D3 may be importan
in that it stimulated calcium absorption, calcium
retention and plasma alkaline phosphatase, but
without increasing indirect indices of bone resorp'-
tion (6 studies). Studies in health suggest that
24,25(OH)2o3 is produced when other vitamin D
metabolites are administered, and it is therefore
possible that the induction of osteomalacia and
its ai]rure to respond to 1,25(OH)2D3 in renal
disease reflects in part defective production of
24,35(c*{)2D3. The reputed extrarenal synthesis of
24,25(c*)2D3 might explain the presence of normal
mineralisation in anephric patients. However, our
swn patients without kidneys appear to produce
little or no 24,25(OH)2D3. The importance of
vitamin D in regulating mineralisation in renal
disease thus remains controversial.
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2 YEAR SEQUENTIAL NEMODYNAMIC DATA ON POLYTETRA-
FLUOROETHYLENE (PTFE) GRAFTS USED FOR HEMODIALY-
SIS.
M. Kaye, C. Baird, B. McCloskey and G. Oscar,
Division of Nephrology, Montreal General Hospital
Montreal, Canada.
Looped prosthetic grafts for vascular access are
being increasingly employed. No data is avail-
able regarding the long term hemodynamic effects
of these grafts. Using an indicator dilution
technique for flow (Kaye et al, Clin. Nephrol.
8:533, 1977) and measuring intragraft pressure
directly, 45 grafts were studied at 6 month
intervals. In addition cardiac output was also
measured using a bolus of 1311 albumen. Graft
flow and pressures were remarkably stable in the
same individual unless anatomic changes occurred.
In 11 grafts that clotted or were repaired within
one month of the hemodynamic measurements, mean
flow and pressures were 0.7 L/min and 72 mmHg.
In contrast grafts that continued to function well
had mean flows of 1.6 L/min and pressures of
44 mmHg. These differences were significant,
p <o.ooi. pressure differences between arterial
and venous ends of the graft of > 20 mmHg
indicated stenosis between these ends. Mean
cardiac index was 4.2 L/min and was unchanged
at 4.15 L/min one year later. Two years later
this had dropped to 3.25 L/min, a difference
which was not significant. Mean maximum trans-
verse heart size was initially 15.4 cm and after
an average time interval of 14 months was
unchanged at 15.2 cm. The results show that
cardiac function is normal with graft flows up
to 2.0 L/min. Measurement of graft flow and
pressure is a valuable technique for detecting
abnonnalities of graft function.
COMPARISON OF SOLUTE PERMEABILITY AND REJECTION
CHARACTERISTICS OF NORMAL AND HIGH FLUX CELLULOSE
HENODIALYS IS MEMBRANES
E.Klein, F.F. Holland, and K. Eberle (Intr.
by Benjamin T. Burton)
Gulf South Research Institute, New Orleans,
Louisiana, USA.
The diffusive and convective mass transfer
properties for a series of Cuprophan films,
tubes, and fibers are reported. In addition to
the standard Cuprophan dialysis films and
fibers, a new middle and high ultrafiltration
series suitable for dialysis or hemofiltration
is reported. Boundary layer—free permeability
coefficients of 12 solutes were measured in
saline solution at 37CC using a stirred labora-
tory teat cell. Rejection of solutes was
measured from saline in the presence of albumin
as a function of transmembrane volumetric flux.
Solutes ranged in molecular weight from 1355
(vitamin B—l2) to 17000 (myoglobin). Mass
transfer coefficients for these cellulose films
are compared to those for other types of
polymer membranes. Tritiated water permeability
and hydraulic conductivity are used to estimte
mean pore dimensions and to predict diffusive
permeabilities for noninteractive solutes. A
series of synthetic middle molecular weight
polypept ides are used to correlate charge and
configuration in solution to mass transfer
properties. These experiments Indicate that
clinical correlations based on vitamin B—l2
clearance will under—predict dialysis therapy.
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EVALUATION OF PARTICIPATION OF PARIETAL
PERITONEUM IN DIALYSIS PHYSIOLOGICAL,
MORPHOLOGICAL AND PHARMACOLOGICAL DATA
J.Knapowski, E.Feder, M.Simon & M.Zabel
Depts Pathophysiology and Histology,
University Medical School, Poznai3—Poland
Parietal peritoneu.m makes a surface ro-
ughly estimated as 10% of whole peritone—
ml membrane, however, its participation
i-n water & solutes exchange during dialy-
Gis is unknown, mainly because of lack of
basic physiological data. Using an expe-
rimental procedure of isolation of pieces
of this membrane from rats for in vitro
studies the dimension of diffusion was
estimated for sodium, potassium and. cal—
ciujo, and the values compared with the
ones established for mesentery under the
same conditions. Morphologically (TEM) it
was found that the membrane is covered
with continuous monolayer of mesothelial
flat cells (with high pinocytotic activi-
ty) lying on basement membrane, with
their edges overlapping one another. Des-
truction of the mesothelium executed me-
chanically or chemically with rest of the
structure (incl.basement membrane) remai-
ning intact resulted in a great increase
of all fluxes measured. These results as
well as the observed changes in ion flu-
xes after application of some drugs (Fu—
rosemide, Na—nitroprusside) seem to show
that the parietal mesotheltum not only
determines low permeability of this pen—
toneum for ions but also is the site of
regulation of their diffusion.
USE OF THERMOGRAPHY IN KIDNEY TRANSPLANTA-.
TION:2 YEARS FOLLOW UP STUDY IN 75 CASES.
H.Kopsa,W.Czech,P.Schmidt,J .Zazgornik,
P.Pils,P.Balcke.
1st Med.Clinic,Central Institute of Radio—
diagnostic,University of Vienna,Austnia.
Purpose of the study was to investigate
the diagnostic relevance of thermography
(th)by the method of Tricoire.2loo thermo—
graphic (thc)data were analyzed and compa-
red with ultrasonography,X—ray or renal
scintigraphy.In 45 patients with normal
transplant function skin temperature(t)
over the area of the grafted kidney was 31
—34 degrees(d)of centigrade,being 1—2d hi-
gher than over the opposite lower abdomi-
nal side.Postoperatively t over the graft
region was even 2—4d higher and decreased
within 8 weeks to individual normal range
10 cases with 18 reversible acute rejecti-'
on episodes showed a transient drop of t
from 1—4d.In 30 recipients with chronic
rejection the transplant area was cooler
than the opposite side .Chronic urinary
tract infection(UTI) did not influence the
regional surface t, whereas acute UTI led
to an increase of t in patients with nor—
inal(n=6)and impaired(n=5)renal function.
Clinical suspicion of renal or perirenal
complications could be verified by additi-
onal use of th with a reliability of 9$.
Th as a non invasive,quickly available and
reproduceable method is helpful in patie-
nts with postoperative olig—anunia.Diffe—
rential diagnosis between acute rejection,
occlusion of renal artery and acute tubu-
lar necrosis is possible.
LONG TERM OBSERVATION OF DERMATOLOGICAL FINDINGS
IN RENAL TRANSPLANT RECIPIENTS.
H. Kopsa, P. Schmidt ,J . Zazgornik ,P. Pus ,P.Balcke
J.Thurner. 1st Med.Clinic and 2nd Dermatol.Clinic
University of Vienna. Austria
116 transplant patients with 145 transplants and
a mean observation time of 32.4(1—92)months were
checked at regular intervals(1-8 weeks)for
dermatological findings.
Immunosuppressive therapy with prednisolone and
azathioprine, in 62 cases additionally with ALG
led to skin infections in 104 patients and non
infectious manifestations in 108 patients during
follow up. 85 recipients had mycotic infections,
mainly due to candida albicans; viral infections
in 68 cases were primary caused by herpes virus,
varicella-zoster and the wart virus. In 53 cases
bacterial skin complications were a consequence
of surgery or of impetiginized steroid acne.
Cushingoid changes, such as purpura, altered fat
distribution, lipomatosis, facial erythema, acne,
striae, atrophic and friable skin, generalized
dry skin and hirsutism, as well as hair changes,
such as loss, curling and darkening of the hair,
were also observed. Other findings were
leukoplakia in 1, de novo skin cancer in 1,
hypersensitivity vasculitis in 5, lupus erythemat,
cut, in 1, xanthelasms in 4 and lichen urticatus
associated with preexisting secondary hyper—
parathyroidisrn in 12 cases. Cold intolerance of
the front teeth, parodontosis and increased
frequency of caries was striking.
Regular dermatological controls, adequate therapy
and transient reduction of immunosuppressive
therapy may lower the high incidence of sometimes
fatal compl ications.
RECOVERY OF KIDNEY FUNCTION FOLLOWING PRO-.-
LONGED ACUTE RENAL FAILURE (AR?)
H .KOPSA ,P.Schmidt,J . Zazgornik,P .Pils,
P,Baike.
1st Med.Clinic,University of Vierrna,ustnia
Within 10 years 22 patients(llmale,llferna—
le),mean age 47,6(12—7O)with prolonged
AR? were observed,who underwent success-
ful dialysis treatment for a mean durati-
on of 66,9 days(3O—172).27 haemodialyses
(15—54)were necessary for stabilization
of renal function in 16 patients with oh—
guric and in 6 cases with non—oliguric
prolonged ARF.Causes of ARF were intersti-
tial nephritis in 5,exacerbation of chro-
nic glomerulonephritis in 3,abdominal sur-
gery in 3 and rapidly progressive glome—




bin III deficiency and drug intoxication
caused AR? as well .From onset of' AR? until
the serum creatinine value began to decre-
ase 79,5 days on average( 38—196) elapsed.
9 patients achieved normal renal function,
13 cases had incomplete recovery,8 of them
with severe impaired creatinine clearance
were older than 45 years.Maximum return of
function after prolonged AR? was reached
within 5 1—259 days .Concluding, even prolon-
ged ARF must not be regarded as a hopeless
situation.Early and frequent dialysis to
prevent the development of overt uraemic
symptoms and vigorous therapy of the basic
disease and related complications may sup-
port return of adeouate renal function.
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INTESTINAL RECYCLING JOE) SUBSTITUTION OF
HASMOFILTRATE IN DOGS
P.Kramer, M.Trautmann, 1s.Seegers, D.Matthaei, F.
Holscher, C.Langescheid, R.D.Schersck, F.Scheler
University Hospital, Division of Nephrology
3400 Gottingen, West-Germany
The main advantage of intestinal recycling of
processed haemofiltrate or substitution fluid is
that it does not need to be sterile(inexpensive!).
The overall objective of the project is the de-
velopment of a wearable artificial kidney (WFAK)
without pumps operated solely by the arterio-
venous pressure gradient; ultrafiltrate is ob-
tained continuously as in the natural kidney and
the intestine is used as a 'renal tubule".
The practicability of this concept is sup-
ported by the results of the following studies:
a) Haemofiltrate was administered into the duo-
denum of 5 ambulatory dogs through an implanted
silastic catheter at a rate of 5-10 ml/min. None
of the dogs presented signs of discomfort or suf-
fered from regurgitation or diarrhea. All 5 dogs
had solid stool, enhanced diuresis and no change
in body weight over a time period of B hours.
b) Filtration rates between 5—10 ml/min were ob-
tained in 7 ambulatory dogs after connecting an
ANICON-IN-LINE-ULTRAFILTER with an external a.v.
shunt. Intestinal recycling rate as a rule was
2 ml/min lower than free flow ultrafiltration.
c) Recirculation of autologous haemofiltrate in
5 uremic dogs indicated unselective reabsorption
of all electrolytes and small molecules.
d) First experiments with intestinal substitution
of ultrafiltrate by an unsterile Ringer's lactate
solution resulted in a decrease in plasma—K,
—creatinine and —BON, whereas plasma—Ca, —Cl and
—HCO, remained unchanged.
VALUE OF BIOCHEMICAL MEASUREMENTS ON THE RESIDUAL
PERITONEAL FLUID IN £'ATIENTS ON CHRONIC INTER-
MITTENT PERITONEAL DIALYSIS.
G.Lamjy, B, Coevoet, JF de Fremont, JM Hardin,
A. Fournier.
CFIU Amiens, France.
To verify to which extent the measurements
made on residual peritoneal fluid (RPF) reflect
those made on the plasma, various biochemical
measurements were made simultaneously on 20 speci-'
mens of RPF and plasma taken just before connec-
ting patients on chronic intermittent peritoneal
dialysis (CI&'D), There was no significant diffe-
rence between plasma and RPF values of sodium,
potassium, chloride, phosphorus, urea and creati—
nine. On the other hand calcium, protein and
bicarbonate were significantly lower in RPF than
in plasma, Plasma calcium may be calculated with
S Z error from RPFCa because of a significant
regression (r 0.81). It is equal to 32+.8S
NPFCa. Because of a poor correlation (r-'. 60)
plasma protein cannot be accurately calculated
from RPF protein concentration. The lower HC03
in the Rt'F cannot be explained by the GIBBS
DONNAN law but may be explained by stagnation of
lactate which is used as buffer in the dialysate.
In conclusion, except for protein the usual
biochemical parameters used for the control of
uremic patients on CIPD can be made on RPF
avoiding useless blood loss which contributes
to worsen patients anemia,
A STuDY OF PAIRED NECRO KIDNEY GRAFTS.
L.IJ.Lamm for Scandiatranspiant and EDTA Registra-
tion Committee (Intr. by A.J. Wing).
Comparison of the fate of the two kidney
grafts originating from a single donor offers
a rarely used opportunity to control some of the
variables in transplant studies such as condi-
tion of donor and (most importantly) date of
transplantation. This has now been possible for
several hundred cases through a data linkage
exercise between the EDTA registry and a large
European Kidney exchange organization. Prelimi-
nary results of this study showed comparable
survival for transported and not transported
grafts and a significant influence of HLA-A, B
matching in spite of the fact that there was
only an average difference of one ntiseiatch be-
tween the best and worst mathced of the two kid-
neys. This and other results will be reported.
EVIDENCE OF HIGH POLYMERIC I9A LEVELS IN
SERUM OF PATIENTS WITH BERGERS DISEASE . ITS
MODIFICATION WITH PHENYTOIN TREATMENT.
M,L6pez—Trascasa J . Sancho, L . Hernando.
Fundacton Jm&nez Draz,Madrid,Spain.
Recently we have furnished some data showing
the presence of a large amount of serum IgA with
elevated molecular weight in patients with Berger's
disease.The aim of this work was to further define
the biochemical properties of this immunoglobulin
and its modificontion with phepytoin treotment,a
drug that selectively decrease IgA levels. Serum
from 15 patients were studied.The I9A purification
was performed by starch electrophoresis. Fractions
located on the anodk side, containing primarily
the high I9A molecular weight,were subjected to re
duction. The existence of "true polymers' in these
lgA fractions was assessed by searching for the J-
chain on urea alkaline ocrylamide electrophoresis.
The percentages of molecular weight of serum lgA
was established before and after phenytoin treatment
(3 and 6 months) by 5-40% sucrose dcr.sity gradients
All but 4 patients showed a significant increase in
percentage of serum gA on fractions 9—17 S,not
changing at acid pH. i—chain was demostrated in
the five cases studied. After the phenytoin treatment
the patients showed a decrease n polymeric forms
and an increase in nioncrneric pA odopting a pa
ttern similar to the controls.
Our results show the presence of a large amount
of true lgA polymers in the serum of patknts with
Berger's discoe. The return to a normol lgA pattern
after phenytoin treatment suggests thor this drug could
constitute a new therapeutic approach.
MITOGEN- INDUCED LYMPHOCYTE TRANSFORMATION DURING
HAEMODIALYS IS
H.. Ludwig aid-K.-Stummvall
Dept. of Medicine II, Univ. Vienna,Austria.
During haemodialysis (ND) contact with artifi—
cal membranes may result in activation of various
humoral effector mechanisis and in alteration of
dellular components. Thus, it was of interest
to study a) the influence of MD on mitogen indu-
ced lymphocyte (Ly) transformation (LT) and b) th8
influence of patients plasma drawn at different
times during MD on LT of control Ly.
PHA—,.ConA- and PWM-induced LT (micromethod
using both whole blood and isolated Ly) at time 0,
as well as 30,60 and 240 minutes after HD was stu-
died in 13 chronic uraemic pts. In addition, LT
of isolated Ly of 7 healthy controls incubated
with pt. plasma drawn at different times during
MD waa studied.
A slgnificantly decreased PHA—, ConA- and PWM-
induced LT (whole blood method) was observed after
30 minutes of MD. Thirty minutes later reduced LT
returned to predialysis levels and showed a fur-
ther strong jocrease over predialysis levels after
240 minutes of MD. In control Ly incubated with
plasma drawn 30 minutes after onset of MD a re-
duction of LT was also found. However, in the lat-
ter test system,decrease of the 30 minutes values
did not reach levels of sigriificancy, since a
rather wide variation of individual LT values was
obtained by incubating control Ly with plasma
drawn at 0,60 and 240 minutes.
-ConClusion: Both, alteration of lymphocytes
as well as activation of serum factors seem to
account for the significantly decreased PHA—,
ConA-, and PWM-induced LT (whole blood method) ob-
served 30 minutes after onset of ND.
?J\I'1iCENESIS OF liyi-OPIDSP}-IATEM]IA IN KIDNEY
NFMixjpAFr PEMIP1ENTS: A NTLLFD TRIAL.
S. Madsen, K. Ølgaard, Di. Lund, Bj. Lund
& 0. H. Sørensen. Nephrological Dept. P,
Rigshospitalet; Medical Dept. E, Frede—
rikshcrg Hospital; Dept. of Orthopedic
Surg. , ITillerd Hospital and Medical
Dept. F, Honey Hospital, Dennark.
Pathogenesis of posttranso.lant hype—phosphatemia was studied in a controlled
trial of 10 normo-- and 10 hypophosphat—
emic necrograft recipients. The groups
were comparable as regards age, sex, du-
ration of uremia, GER and immunosuppres-
sive therapy. Several parameters affect-ing the renal handling of P were investi-
gated, including measurements o
l.25(OH)2D3, 25(OH)D3, Ca and i—PTH.Disturbances of calcium— and vit.—D me-
tabolism were evident: 45% of the pati-
ents had low l.25(OH) 0 and 10% low
25(OH)D3; lo% had incesed Ca++ and 5o%
increased i—PTH. 1-owever, l.25(OH)2D
25(OH)D , Ca+ and i-PTH did not difer
in the wo groups and in neither group
were l.25(OH)2D3, 25(OH)D3 and Ca le-
vels correlated with the renal handling
of P, which in normophosphatemic pati-
ents is inversely correlated with i—PTH.
The hypophosphatemic patients showed no
such correlation. The data suggest that
hypophosphatemic patients exhibit a ma-
jor defect in the PTH mediated tubular
transport of P. This defect may be caused
by selective ischemic tubular damage of
the P transport in the kidney graft.
OXALATE REMOVAL BY DIALYSIS AND HEMOPERFU-
SION
Q. Maggiore,A.Poggi,S. Parlongo,T. Cerrai
Centro Fisiologia Clinica CNN, Regglo Ca-
labria, Italy.
Uremin oxalotic patients under trice
weekly RDT fare very poorly. To improve
the treatment efficacy, we studied the ef-
fects of 5 h daily dialysis (hollow fiber
dialyzer) and hemoperfusion on the oxalate
serum levels in three patients sith prima-
ry oxaluria who had been under RDT since
4—8 years. Serum oxalate was determined in
plasma ultrafiltrate by a modification of
the Hodgkinson and Williams method. In non
oxalotic patients under trice weekly RDT
plasma oxalate levels were 410 and 256g/
dl (pre— and post—dialysis mean values,
respectively) . In oxalotic patients under
the same dialysis schedule the average
plasma levels were 1130 and 680 )g,dl.
After two months of daily dialyses plasma
oxalate values were 805 and 540 .g1dl.
2 hour hemoperfusion over 280 g activated
charcoal brought about a 44% drop in oxa-
late plasma levels.
Treatment with daily dialyses is not
effective in reducing the plasma oxalate
to the levels of non oxalotic uremic pa-
tients under trice weekly ROT. Charcoal
hemoperfusion effectiveness compares with
that of hemodialysis.
FETAL LIVER TRA1SPIJJ1T IN PABRY!S DIA
N.C.Ealik,J.L.Touraine,E.Perrot and J.Traeger
Clinic of Nephrology,Lyon,France.
Two patients,33 and 26 years old,presented with
clinical manifestations of Fabry's diseae.The dia-
gnosis war confirmed by ophtalmologic,histological
and enzymatic studies.Because of inefficacity of
treatment with plasma transfusions and of symptoma-
tic therapies,a transplant of fetal liver cells
with normal enzymatic activities was performed.In
the first case,objective and subjective clinical
symptoms were significantly intproved:sweating ap-
peared for the first time and became normal,cutane—
ous lesions appeared slightly decreased and pains
disappeared.This improvement of extra renal manifes.
tations of the disease with this new treatment was
comparable to that obtained with kidney transplan—
tation,and was still persistent 3 years after the
fetal liver transplant.The viability of the fetal
liver transplant was initially followed using dosa-
ges of circulating alphafoetoprotein.In the second
case it is too early to evaluate the efficacy of
the trsnsplant,especially as the patient had normal
sweating and relatively few pains except at the
cold season.The mechanism which may be held respon-
sible for improvement of our patients,as of reci-
pients of a kidney transplant,is not completely
elucidated.The cells,rather than steroids or ama—
thioprine,seemed to support the efficacy.From the
results observed after several years will derive
the significance of this therapeutic approach in
Fabry's disease and,more gcnerally,in many diseases
associated with a genetic enzyme deficiency.The
initial renal involvement presently appears to be
stabilized but it will be important to determine
whether alteration of renal function will develop.
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IS IT REI\LLY WORIII RETRTNSPLThRflNG PATIENEN?
A. Barni, P. Mddes tar, D .B. Evans and N.Y .Calne
depaxbrentUSurgery, Cambridge University20% of renal allografts in Europe are second
allografts and a pool of previously transplanted
patients are ncai seen in nest dialysis centres.Opelz and Terasalci have failed to confirm that
first allografts significantly irrmunise a reciei-
ent and careful iiimunolpoical screening elimi-
nates those in whcm accelerated rejection will
occur. Non—ixmiunological paraireters were re—
viewed to assess their importance in subsequent
allograft function. A study of retranspiantation
in one unit over a 10-year period revealed 77
patients had a second allograft, 6 a third, one
a 4th, one a 5th and one a 6th renal allograft.
No significant difference in allograft survi-
val was found between first and subsequent allo-
grafts nor was the nortality different. The
cause of primary renal allograft failure did not
influsnce the outcrae of the subsequent grafts,
although a delay of longer than a year between
allcxprafts was due to difficulties in obtaining
a negative cross—match.
Tedinical difficulties with retransplantation
were frequently encountered with allografts often
having to be placed within the peritoneal cavity.
The difficulties in nonitoring intraperitoneal
allografts will be discussed. Non- irrmunological
factors, previously thought to be iiriportant in
subsequent allograft survival have not, in this
one centre study, shan themselves to be rele-
vant. The subseqnt retransplantation of
patients in whciii primary allograft fails seemsjustified in terms of survival and quality of
rehabilitation but requires iimticulous surgical
managenmnt.
EVIDENCE OF AUJMINIIJM ACCUBJIATION IN RENAL
FAILURE
S. Mareden, 1.5. Parkinson, M.K. Ward, H.A. Ellis
and D.N.S. Kerr
Royal Victoria Infirmary, Newcastle upon Tyne,
England.
Aluminium accumulation in patients on haemo—
dialysis cruses dialysis encephalopathy and
Vitamin D resistent osteorralacia. (Ward et a).
1978 Lancet 1:841—845). Berlyne et a). 1970
Lancet 2:494—496 documented hyperalumineama in
renal failure from aluminium resins. Using
flameless atomic absorption spectrophotometry we
can confirm these findings and show accumulation
of aluminium in serum and bone in patients with
renal failure prior to haemodialysis. In 13
patients with chronic renal fai are the mean
serum aluminium concentration was 9.5 ugh 5.4
range 5—26 (no aluminium containing phosphate
binders), in 12 patients with chronic renal
failure taking aluminium hydroxide mea serum
aluminium concentration was 60.3 ug/l — 70 range
8—278 (P<0.05) (normal (28) mean 5.5 ug/l
2.9 range 1—15). Using neutron activation
analysis bone aluminium in normals (8) was 5.7
1 ppm/Ash where patients with chronic renal
failure (9) aluminium concentration was 22.4 9
ppm/Ash. Aluminium accumulation starts prior to
end stage renal failure and is associated with
aluminium containing medications.
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THERMOGRAPHY (TB) : AN ALTERNATIVE TO ANGIOCRAPHY
(AN) FOR VASCULAR ACCESS SURVEY IN HAEMODIALYSIS.
J.P. }lasselot, J.P. Adhmar, J. Leederich, D.
K1einknech.
Service de NphroIogie, Nontreuil — Paris, France.
AN is until now the only possible survey of ar-
teriovenous fistulae (AVF) in haemodialysis pa-
tients ; it may be a painful and feared method in
8ome of them, and Cannot be easily repeated. Du-
ring the past year, information given by TB and AN
was systematically compared in our haemodialysis
patients Flexible tapes of encapsulated liquid
crystals , temperature (Ta) range 34—36CC, were
used ; some patients with low flow AVF were inves-
tigated with tapes, T range 32-34C. The tape
being applied upon the AVF, a flashlight photo-
graph was taken perpendicularly td the arm. The
vessels appeared in blue on a black background.
Thirty-three patients were studied, including
23 with Cimino AVF (20 radial, 3 humeral), 8 with
saphenous homografts and 2 with bovine hetero-
grafts. In patients with Cimino AVF, TM showed in
13 cases a blood flow stealing through collateral
veins, leading to surgical ligature in 5, and a
stenosis of the main vein in 4 other cases. In 6
grafted patients, a narrowing of the venous anas—
tomosie was detected, requiring a surgical repair
in 5. In all, AN confirmed thermographic findings.
TB failed in 2 cases with etenosis of the radial
artery, and in one case with humero-axillary homo-
graft.
In conclusion, TB seems a quick, simple and sa-
fe method for vascular access aurvey in hsemodia-
lysis patients. It can be repeated and should res-
trict AN to the only patients for whom a surgical
revision of the AVF is mandatory.
* Bayer Pharma, Leverkusen, FRG.
REDUCTION OF UNFAVOURABLE EFFECTS OF
HEPARIN WITH USE OF GABEXATE MESILATE IN
DIALYSIS
Matsui,N.,Nakagawa,S.,Sasaoka,T.,Suenaga,
M.,Yoshiyama,N. and Takeuchi,J. (intr.D.Kerr)
Tokyo Medical and Denal University, Japan
Although heparin is used as the routine
anticoagulant in haemodialysis, it has
certain demerits: it cannot inhibit the
contact phase of the intrinsic coagulation
system such as the plasma kallikrein—kinin
system (PKKS): it can cause allergic
reactions and induce lipolytic activity;
it needs antithrombin 111 for biological
effect.Gabexin mesilate which acts as a potentinhibitor of all proteinases of intrinsic
coagulation and is not antigenic was
studied as a possible alternative to
heparin. In vitro, gabexate maleateinhibited PKKS while heparin did not.
Infusion of 300 mg gabexate mesilate and
300 IU heparin per hour in clinical
dialysis prevented clot formation, and
inhibited PKKS, without unnecessary
prolongation of bleeding time or elevation
of free fatty acids. The effects were very
similar to regional heparinisation withoutits complications.
Conclusion: Gabexate mesilate is a
possible alternative for heparin which can
be used on patients with a bleeding
tendency.
PLASMA KETO ANALOGUES IN EREMIC PATIENTS
D. Matthaeia, p. Schauder , p. Eramera,
i'ieler, A. MenchHOinowskyc, U. Langenbeck'
Department of Medicine, Division of Nephrology (a)
Division of Gastroonterology (b), Institute of
Human Gonetica (c) , University of Gdttingen,
Federal Republic of Germany
When given to patients on dialysis treatment
or those with compensated renal failure branched—
chain keto acids (BCEA's) are said to reduce urea
generation and uremic symptoms. However, the
plosma levels of BCKA's, i.e. mlpha—keto—iso—
caproiec acid (KICA) , alpha—keto—isovaleric acid
(KIVA) and alpha—keto-B--methyl-n—valeric acid
(KMVA), in uremic patients have not been pre-
viously reported on. Reduced fasting plasma
levels of BCKA's (KIVA 7.9 pmol/l, RICA 12.0
prsol/l and KMVA 4.6 pmol/l) were found in patient
on hemodialysis as compared to normal controls
(KIVA 12.g pmol/l, KICA 33.5 pmol/l end KMVA
22.7 pisol/l). There was an increase in plasma
BCKA's to normal values in patients on hemo—
filtration after treatment, although conside-
rable amounts of BCKA's were eliminated. This
gives evidence of low protein binding of these
substances. A negative correlation between
fasting plasma HCKA's and serum—creatinine/urem
points to a specific deficiency in uremia. Keto
analogues, when administered to patients with
uremia, did not alter serum fasting leveld sig-
nificantly. In conclusion, the possibility to
measure kato acids in plasma offers new aspects
of keto acid and amino acid metabolism and pos-
sibly of dietary treatment of uremia.
POST—TRANSPLANT (TX) RYPERPARATHYROIDISH (RPm):
RETAINED CONTROL BY IONIZED Ca.
D.A. McCarron, S. Krutzik, J. Bmrry, R.S. Huther,
and WA'!. Bennett. Univereity of Oregon Health
Sciences Center, Portland, Oregon, U.S.A.
Post—Tx HPTH is believed to represent an au-
tonomous state with failure of normal regulation
by iCa. We sought to define t4 response of Tx—
112TH glands to changes in iCa and the effect of
alteration in PTB—C handling in the post—Tx state,
Paired measurements of iCa (by ion—specific elec-
trode) and PTH (by both a 50% N—/5O% C—terminal
inununoassay and C—terminal specific immunoassay)
were made over a wide range of iCa (1.2 to 5.0
mEq/L) in 8 normal and 13 successful, HPTH, Tx
recipients in the basal state and during a 2°EDTA
(50 mg/Kg) and a 6° Ca' (15 mg/Kg) infusion.
Our data defined a significant(P<.OOl) inverse
logarithmic relationship between iCa and PTH—N/C
for NL(N=75) and Tx(N=l27). Similar relationahipa
were also demonstrable u"ing the PTH—C aaaay.
Throughout the ran, e of a studied, PTB concen-
trations were significe.,.rly higher in the Tx,thus
confirming the altered sensitivity of 112TH glands
to iCa. Of note, though, the slopes of the two
logarithmic'curves did not differ, indicating
similar responsiveness of PTH secretion to acute
changes in iCa for both NL and Tx—HPTH subjects.
In conclusion, we have demonstrated m predict-
able, inverse, logarithmic relationship between
iCa and FF11 in both Nt and Tx—HPTH subjects. Our
findings indicate that Tx—HPTR glands are not au-
tonomous in terms of their regulation by and/or
responsiveness to acute changes in iCs. In addi-
tion, the increased setpoint for iCa's regulation
of PTR release in Tx—HPTH cannot be accounted for
by altered handling of PTH—C.
VASODEPRESSIVE EFFECT OF PARATHORNONE IN POST—
TRANSPLANT (P—Tx) BLOOD PRESSURE (BP) REGULATION.
D.A. NcCarron, S. Krutzik, J. Barry, 5.11. Plant,
and WA'!. Bennett. University of Oregon Health
Sciences Center, Portland, Oregon, U.S.A.
Persistent hyperparathyroidism (112TH) and its
attendant hypercalcemia have been implicated as
contributing factors in some cases of P—Tx hyper-
tension. In order to define PTH'e mod hypercal—
cemia's role in P—Tx BP regulation, we measured
BP, ionized Cm (iCa), PTH and PRA during m 4—hr
Cs infusion (15 mg/Kg) in 7 Nt subjects and 13
successful Tx recipients with 112TH.
Systolic BP (SBP) and iCa increased while PTH
decreased during the Ca infusion in both groups
PRA did not significantly chmnge. The increases
in iCa mmd SBP were similar for both groups; how-
ever, the decrease in PTR was significantly
(P <.005) greater in the Tx—HPTR subjects. For
both Tx(N=37, r—. 53, P<.OOl) and NL(N2l, r—. 44,
Pc.O5) there was a significant negative correla-
tion of the relative change (Ed) in PTH with Ed
5112 at all sampling intervals during the Ca in-
fusion. The more PIll was suppressed, the more SBP
increased. Of note, the slopes of the linear re-
gression equations for NL and Tx did not differ
from one another. In the Tx subjects, the Ed iCe
was also correlated (Pc.Ol) with a Ed SBP. No
such relationship existed in the Nt. No relation-
ship existed between PRA and either iCs or SBP.
We conclude: 1) endogenous PTH contributes to
HP regulation in both P—Tx HPTH and Nt, acting as
a vasodepressor; 2) RPTH alone does not increase
BP; and 3) the HP response of Nt and 112TH sub-
jects to hypercalcemis is dependent in part upon
the degree of endogenous PIll suppression and not
necessarily the increase in serum Ca.
LOW DOSE STEROID FROM THE DAY FOLLDWIMG RENAL
TRANSPLANTATION
Mary G. McGeown, 3.F. Douglas, W.A. Brown,
S. Mehta, Claire M. Hill.
Renal Unit, Belfast City Hospital, Belfast,
Northern Ireland.
High dosage of steroid nay lead to obesity,
cushingoid appearance, in,reased risk of death
from infection, gastrointestinal coaplicatiuns,
diabetes or serious disability from avascular
necrosis of bone. However, many units use large
doses of steroid innediately after grafting.
We have used a low dose of steroid (20 ag of
prednisolone) coanencing the day after trans-
plantation, for 151 consecutive renal transplants
(146 cadaver, S living related donors). The only
other iaaunosuppression used is azathioprine.
109 of 151 grafts continue to function for
periods of 1 aonth to 10 years and of 42 grafts
lost 17 failed froa rejection. The conparatively
few grafts lost from rejection show that low
dosage of steroid combined with azathioprina
provides effective ianunosuppression.
Ho patient died from infection during the first
3 months after transplantation and the overall
infection rate has been low. 1 patient only died
from gastrointestinal disease. 2 patients devel-
oped acute hyperglycaenia; both survived. Ho
patient has reguLed hip joint replacenent and
only 2 have hip pain (in 1, hip joint disease
antedated the transplant). X—ray screening of 50
unselected patients have revealed no further case
of avascular necrosis.
The low incidence of graft failure froa reject-
ion and of serious complications, aake low dose




LYMPHOCYTE MARKERS AND CIRCULATING IMMUNO COMPLE-
XES IN PRIMARY GLOMFRIJLONEPJ-IRITIS (FG).
Meroni P.L., Dall'AglioP., Balestrieri G., Afle-
gri L., Cibodda G.F., Colombo G., Tincani A.Clinica Medica e Nefrologia UniversitO di Parma
Clinica Medica IV Universitb d-i Milano
Serv. di Tiamunologia Clinica Sped. Civ. di Bresci
In 46 patients with PG (minimal changes, rnesan-
gioprol ipherative, mesangiocapil lary, membranous,
focal glciiierulosclerosis) the different peripheTal
lymphocyte populations B, BA, EAC(C3d) rosette for
sung cells (RFC) and with surface membrane immuno
globulins (SmIg) cells (screened by polyspecif Ic
antisera against all iimmmoglobulin classes andmo
nospecific antisera anti IgM,IgD,IgG,IgA) were va
lued. Immunofluorescent staining procedure was ca
ned out after cells incubation at 37°C to remove
extrinsic Ig from cells surface. The cOncentration
of immunocomplexes(IC) by C1qbinding assay(C1Q-BA)
and conglutinin binding assay (KgB-SP),of Ig and
complement fractions(C3,C4)and some renal function
parameters were also determined. Varition Qf low
meaning,cnflpaniflg to a normal population similar
as far as age and sex,were shown for E-RFC and PA
RFC,while a decrease of EAC-RFC as observed in
29% of cases. Within the SmIg lymphocytes those
with SmIgG were increased in 63% of cases. Thede
crease of EAC-RFC and the increase of lymphocytes
SmIgG positive were observed more frequently in pa
tients with focal glomerulosclerosis(4/5 cases).
In this group C1Q-BA was positive in more than 50%
By C]Q—BA IC were shown in 35% and by KgB-SPin39%
of cáses(age and sex matched healty subject were
run simultaneouSly: 11% positive at KgB-SP and 3% at
C1Q-BA) .Batween the 2 teeis diffeent results in the
datection cf IC were observed suesting a presence ofdifferent tof IC ii different PG.
URTUARY MAGNESIIJI EXOR2TION (igE) IN DIFFl1T
TYT2S OF IIYPL2CALCIURIA WITH R3GUJ1R1T CALCA—
REOUS NEPHROLITBIASIS(RCN).
L.Minetti°,G. Coluasi°,A. Antonacoi°,A. Arol—
di°°,G. Graziani°°,M. Sunian°
Renal Units,Ospedale HCà Grsnda"° and Policli—
ni000C, Bilan, Italy.
In 36 NCR hypercalciunic(16 intestinal hype-
rabsorbitive—I—,12 renal—N— and 8 tubulophos—
phaturic—TP—)patients,and in 15 normal Subjects
(N)we studied IlgE and CaE(mg/iOO ol GFR)before
and after a Ca load(OL),1 gr. per Os.
Basal MgE was higher in all RON patients
than in N(O.037-fO.O1 Vs O.O25+O.0O9,p-O.OO1);
however R had higher MgE(0.045-FO.O1) than I
(O.034+O.O1)and. TP(O.O31-)O8,p-0.025). After
CL MgR significantly increased from basal valu-
es in N(O.O45+O.O1,+80%,p.0.O01) and in all
RON pa-tients(O.056+0.O2,+58%,pO.O01); however
the increase was +78% in I(O.O61+o.O2,pO.OO1)
and in TP(O.056-fO.O1,p.O.0O1), and only +4% in
R(O.047+O.01,NS).There was a significant corre
lation between the percent increase of I15E and
Casi after CL in N(r=0.98,p.0.OO1),in I(r=0.91,
pO.OO1)and in TP(rO.86,p.O.O1) bit not in R
(r=—O.33,ITS).
In conclusion,basal and after CL hg5 pat-
terns allow to further characterize the diffe-
rent types of hy-percaloiuria.In R hyperoalciu—
rio patients a correlation between Ca and Mg
renal handling seems to be lacking.
USE OF LINEAR MODELS TO INVESTIGATE THE 'CENTRE
EFyECT" ON GRANP SURVIVAL
P.W. Morris for UK Transplant and EDTA
Registration Committee (Intr. by A. J. Wing),
St. Thomas' Hospital, Iondon, U.K.
Six centres with a total of 810 first cadaver
grafts carried out between 1970 and 1976 were
used for analysis. The result of transplantation
was consi red as a binary response, each graft
being classified as a success or a failure
according to whether it survived for 90 days.
Those patients Lost to follow up after less than
90 days, incluing deaths with a functioning
transplant, were excluded. Linear models were
set up to estimate success rates for different
combinations of 6 variables: (1) Centre — 6
groups, (2) Age — 5 groups, (3) HLA match,
A locus — 3 groups, () HLA match, B locus —
3 groups, (5) Blood group match - 3 groups,(6) Year of graft — groups. Data on pre—
sensitization and blood transfusion was
inadequate for analysis.
A linear model evaluating variable (1)
demonstrated a highly significant "centre effect"
(P(.0005). When the linear models were tested
to investigate the centr uffect after variables
(2 — 6) had been allowed for, the "centre effect"
was almost as significant as before (P&.0005).
It is concluded that the "centre effect" is of
paramount importance in determining results of.
kidney transplantation and that the potency of
this effect is influenced by variables other than
those which have been tested for in this
investigation.
EFFECT OF HAEMOFILTRATION (HF) AND HAEMO-
DIALYSIS (HD) ON ERYTHROCYTE ORGANIC
PHOSPHATES IN UREMIC PATIENTS
D. E. Mtiller—Wiefel, B. Kiare, K. SchErer
University Children's Hospital Heidelberg
Fed. Repub. Germany
Red blood cell (RBC) organic phosphate
concentrations which are known to compen-
sate renal anemia partially are influenc-
ed by multiple metabolic factors. 2,3—di—
phosphoglycerate (2,3-DPG) and adenosine—
tniphosphate (ATP) were determined enzy—
matically in 8 patients (9—21 years) with
terminal renal failure immediately before
and after a 6 hours period of HF (Sarto-
rius filter) and HD (Gambro Lundia opti-
ma) under standardized conditions. At the
same time p50, fib, Hct, pH, HCO, inor-
ganic phosphate(P.) and creatinine were
measured in the b±ood. 2,3-DPG and ATP
significantly decreased by HF (mean 4.06
vs. 3.41; 1.94 vs. 1,61 mxnol/l RBC), in
contrast to HD (mean 4,23 vs. 4,40; 2,25
vs. 2,39 mslol/l RBC respecti,vely, n.s.)
p50 decreased after HF and remained con-
stant after HO. With both prxedures pH
and HC03 rose and P. and creatinine de-
creased at a similar1degree, whereas fib
and Hct increased only after HF. 2,3—DPG
correlated with Hb (r = -0.61) and pH
(r = 0.41), but ATP only with Hb(r=—0.70).
These data suggest that after HF,in con-
trast to HD,the fall of RBC organic phos-
phates,increasing oxygen affinity of Hb,is due to haemoconcentration.
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RENAL REFLUX SCARRING CYSTOMETROGRAPHY AND TISSUE
TYPES
Munson K.W, Packham D.A, Thompson P, Kennedy L,
Parsons V.
Departments of Urology and Nephrology, Kings
College Hospital and Guys Hospital Tissue Typing
Laboratory, London.
Three families containing thirteen members with
renal carring and/or ureteric reflux in two gen-
erations were investigated by pyelography, cysto-
metrography and tissue typing. The type of
scarring varied between clubbing of calyces with
scarring opposite the calyx typical of radiolog-
ically defined pyelonephritis, polar cortical
atrophy, total cortical atrophy with shortening
of renal length; often major changes occurred
unilaterally on the same side in each member of a
family, left sided abnormalities predominated
(9/13) in the remainder (4/13) the changes were
equal and bilateral. Reflux occurred in all
systems with severe changes. In view of the
possibility that a physiological abnormality of
neuromuscular coordination in the bladder and
ureters was what was inherited rather than an
anatomical one cystometrograms were performed in
the majority of subjects and found to have normal
pressure flow relationships. Tissue typing re-
vealed an excess of A9 and W27. A retrospective
survey of patients transplanted with proven re—
flux and subsequent nephrectomy revealed a
similar tissue type excess. These findings raise
an important genetic influence in the development
of.reflux and scarring seeing infection as a
mechanism for detection of this abnormality
rather than a dominant causative factor.
IHE INFUJENCE OF ACETATE VERSUS BICARBONATE ON
PATIENT SYMPTOMATOLOJY DUPING DIALYSIS
K. Nagai, N. Pagel, T. Rattazzi, J. Vizzo, B.H.
Scribner
University of Washington, Seattle, WA, U.S.A.
Previous results (Ann mt Med 88:532, 1978)
denmnstrated that when acetate is used in a large
surface area dialyzer (LS-A) some patients become
quite syrnptomat ic when compared to using bicar—
txnate (ES-B). To determine whether the symptoms
are due to the high blood levels of acetate, or
to the fluctuations in plasma bicarbonate, we
compared 3 dialysis strategies: ES-A, ES-B and
ES—A + B. Dialysate levels of acetate and bicar—
bonate in the ES-A + B strategy were adjusted to
give the same acetate load as ES-A and the sane
plasma bicarbonate changes as ES-B. Results of 5
dialyses of each type in 10 patients confirmed
that these goals were achieved with the ES-A + B
strategy. However, when the patients were on
ES-A + B, their plasma pH was slightly higher at
the end of dialysis. Objective performance tests
given before and after each of the 15 single-blind
dialysis experiments showed no significant deteri-
oration in performance with ES-B dialysis. In
contrast, there was significant deterioration with
ES-A and ES-A + B dialysis. Symptom check lists
recorded by patients were consistent with these
results. Significantly greater severity of
symptoms was associated with ES-A and ES-A + B
dialysis. These results suggest that elevated
serum acetate levels rather than changes in acid-
base balance are primarily responsible for the
morbidity. Further analysis of the data indi-
cated a highly significant correlation between
serum acetate levels off dialysis and decrements
in performance on the objective tests.
POST-TRANSPLANT HYPERLIPIDEMIA : INCIDENCE, LONG-
TERM EVOLUTION AND CAUSAL FACTORS. M.L. Nicholas,
8.5.3. Alexandre, C. van Ypersele de Strihou.
cliniques Universitaires St—Luc, Renal and Trans-
plantation Services, University of Louvain,
Louvain en Woluwd, Belgium.
We have evaluated the incidence, long-term evo-
lution and pathogenesis of post—transplant hyper—
lipidemia (HL) in 88 transplanted patients without
nephrotic syndrome follcwed for 2 to 13 years by
the same staff.
Among the 412 lipid profiles, 63.1% were normal
10.2% ha, 13.1% lIb, 12.1% IV, 1.5% V. Incidence
of HL decreased over the years (51,40,31,30 and
25% after 2,4,6,8 and jo years) . Patients without
HL at 2 years remained subsequently normal. By
contrast, 13 with 1-IL at 2 years became normal.
No significant relationship was found at 2 and
4 years between HL and steroid dosage, obesity,
diabetes or sex. Incidence of HL was higher in
patients with serum creatinine > 1.2 mg/dl.
Normalization of HL occurred in 13 patients with-
out changes in steroid dosage, bodyweight or seru5
creatinine. Age was significantly associated with
ilL. At 10 years atheromatous lesions were not more
frequent in HL than in patients with normal
lipids.
We conclude that ilL decreases spontaneously
over the years after transplantation, a fact to
be taken into account when evaluating post—trans-
plant ilL. Several factors are involved in its
genesis. No long—term deleterious effect of ilL
was observed within the limits of this study.
ORTHOPAEDIC COMPLICATIONS OF RENAL
TRANSPLANTATION
John Nixon, Se8n Hughes and John Castro
Department ot Surgery,. rlananmrsmith Hospital
and Royal Postgraduate Medical School,
London, England.
Between 1973 and 1978 318 renal transplants
have been performed at Hammersmith Hospital.
During this period we have treated surgically
12 patients for avascular necrosis of the
head of the femur, femoral condyles, and
humerus, by total hip and shoulder prosthesis,
and arthrodesis of the knee. We wish to
present the results of our treatment including
the complications. These complications
include excessive blood loss, infection)and
delay in the rate of fusion, which we believeis related to the structure of the bones. We
wish to conclude that contemporary
orthopaedic treatment is justifiable producing
excellent results in these patients, providing
adequate blood and antibiotic cover is
available.
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VASOPRESSIN RESPONSE IN HEMODIALYSIS PATIENTS.
E. Nord, G.M. Danovitch (Intr. by J. Rosenfeld)
Ben-Gurion Univ. Dept. Neph. Beersheva, Israel.
Plasma vasopressin (VP) was determined by RIA
in 10 patients on maintenance hemodialysis (MHD).
In each patient repeated studies were performed
under conditions of manipulated change in effec-
tive plasma osmolarity ([P0) (varying dialysate
Na), and blood volume (DV) (ultrafiltration).
Blood was drawn under carefully controlled con-
ditions at commencement and completion of a 4hr
dialysis. A total of 44 studies was performed.
Mean VP levels at commencement of study were
4.95(SEM±O.56)pglml compared to <1.Opg/ml for nor
mel controls. In 15 studies VP levels increased
following dialysis; in 5 this was an appropriate
response to increase in [P0 and decrease in BV;
7 in response to a decrease in BV despite a fall
in [P0; 2 in response to a rise in [P0 despite
a fall in DV; in 1 VP rose desoite a fall in EPO
and increase in BY. In 29 studies VP level drop-
ped, of these 5 responded appropriately to a dec-
rease in EPO and increase in DV; 19 n response
to a decrease in [P0 despite an increase in BY; 1
in response tQ a decrease in BY despite an in-
crease in EPO; in 4 VP dropped despite an in-
crease in [PD and decrease in BV.
We therefore conclude that 1. Patients on WHO
have higher VP levels than normal controls. 2. VP
secretion responded appropriately to either
changing BY or [P0 or both in 89% of studies,
while in 11% an inappropriate response to both
major stimuli to VP release was documented. 3. It
was not possible to predict in any given study to
which stimulus VP release would respond. VP re-
lease is similar qualitatively but differs quanti-
tatively in WHO patients as compared to normals.
PROLONGATION OF RENAL p,LrxXRAFr SURVTThL IN DLA-
TISSUE TYPED BEAGLES AFTER THIRD PARTY LEU(DCYTE/
ERI'rHBOCYTE TRANSFUSIONS.
H. 6bertop, A.B. Bijnen, H.N. Vrieseridorp,
R.H. Schreve, D.L. Westhrcek.
Lab, for exp. surgery/dept. of surgery, Erasmus
Univeristy, Rotterdam, the Netherlands.
In earlier exparinients significant kidney graft
protection by three third party whole blond trans-fusions prior to kidney transplantation was ob-
tained in beagles. Data on the effect of three
erythrocyte or leucocyte transfusions in the same
model will be given in this presentation. Thans—
fus ions were given in weekly intervals and kidney
transplantation was performed two weeks after the
last transfusion. Kidney donors were mismatched
for SD and LD antigens. Iriuiunosuppression was
given p.o. (Inn. + Predn.) up tifl 60 days. Survi-
val tijrs in days canpared with results with






+ = positive cross-match before transplantation
between kidney donor and recipient.
Conclusions:
1. the protective effect of third party blcxxl
transfusions on renal allografts could not solely
be contributed to the erythrocytes or leucocytes.
2. a pure erythrocyte suspension could indnce
lyrnphocytotoxins.
3. the presence of a positive cross—match was not
correlated with accelerated graft rejection in
all cases
A TICKET TO FREEDOM WITH CONTINUOUS
AMBULATORY PERITONEAL DIALYSIS (cAPD)
D.C. Oreopoulos
A 16 mm Colour-Sound Movie.
After a short introduction discussing
the historical development of peritoneal
dialysis, this movie describes thedetails of the Toronto Western Hospital
technique for CAPD (change of the plastic
bags, daily change of the dressings and
weekly change of the tubing)
EXPERIENCE WITH CONTINUOUS AMBULATORY PERITONEAL
DIALYSIS (CAPD). D.C. Oreopoulos,S.Clayton, N.
Dosbros ,A.Katirtzoglou,G.Zellerman. Toronto
Western Hospital, Toronto, Canada.
Sixty—six patients (28 men,38 women) with ages
ranging from 11 to 74 years were treated with
CAPD from 1 to 14 months (average 6.4 months).
Training for CAPD took an average of 10 days.
Fifty—three patients were trained to change the
tubing themselves,whereas in the remaining 13 the
tubing was changed by a nurse. Most of the pat-
ients (52) were exchanging 4 bags/day,7 days/week
Eight patients,who,on this scheme had a serum
creatinine (Cr) below 10 mg%,were allowed to ex-
change 3 bags/day whereas 6 patients whose serum
Cr was above 15 mg% were asked to exchange 5 bags
/day. The average last biochemical values were:
serum Cr: ll.7mg%,BUN: 59.2mg%,Ca: 9.2mg%,P:
4.6mg%,K: 4.2mEq/L,Proteins: 6.4grn%,Albumin:
3.4gm%,Hb: 8.7gm%,triglycerides: 339mg% and cho-
lesterol: 238mg%. Seven patients received a
kidney transplant,lO returned to in—centre PD,3
transferred to hemodialysis,3 died and 44 are
still on CAPD. Some of the complications that we
encountered were: hypotension (24) ,arthralgia
(15) ,nausea/vomiting(I5) ,back pain (11) ,malaise
(9),ankle swelling (7),insomnia (5),muscle cramps
(5) ,pruritus (5) ,poor appetite (4) ,deterioration
of hemorrhoids (3). A total of 56 episodes of
peritonitis occurred among 33 patients,an in-
cidence of 50% among the patients or one episode
every 7.6 patient months. Most of these episodes
(70%) were due to grain positive cocci. Poor tech—
nique,poor personal hygiene and problems with the
tubing and the connections were related to many
of these episodes. CAPD is a promising dialysis
treatment suitable for a large percentage of
Datients with end stage renal failure.
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TREATMENT OF UREMIC PERIPHERAL NEURITIS BY DIRECT
HEMOPERFUSION WITH ACTIVATED CHARCOAL
O.Otsubo,K. Kihara, Y. Simada, J. Yamauchi,
I. Takahashi, Y. Yarnada, T. .Inou (Intr. K. Ot)
The Inst. of Medical Science, Teh Univ. of Tokyo
The middle-molecular substance theory has been
proposed as the cause of peripheral neuritis in
the patients on hemodialysis, and the square meter
hour hypothesis was proposed as the therapy.
However, we have obtained favorable results in
the treatment of peripheral neuritis in the
patients on hemodialysis by direct hemoperfusion
with activated charcoal which absorbs well the
middle—molecular substances.
EMG and auditory acuity tests were performedth
check peripheral neuropathy in the patients on
hemodialysis, and biopsies of the muscle and nerve
were made on the patients with severe subjective
symptoms. These patients were treated by direct
hemoperfusion with a column packed with 170gm of
hydron-coated petleurium connected in series with
HFAK, over 3 hours each time, 3 days a week, for
2-3 months, and investigated for alterations in
subjectve symptoms and those in EMG.
Auditory disturbances were found in 65% of 196
patients on hemodialysis, and abnormalities on
theEMG were noted in 23% of them. Nine of them
were the patients with peripheral neuritis associ-
ated with subjective syptoms:and direct hemoper—
fusion them resulted in no changes in one, but
apparent improvements both in subjective symptoms
and ENG in the other 8.
As descibed above, direct hemoperfusion with
HCAC has proved to be a potent treatment of peri-
pheral neuritis in the patients on hemodialysis,
and this findings appears to support the middle—
molecular substance theory.
ENDOTHELThL ANTIBODIES IN PENAL TRANSPLANTATION.
L.C.Paul, L.A.van Es, F.H.J.Claas, M.W. Kalf C.
Departments of Nephrology and Imrnunohematology,
University Hospital, Leiden, The Netherlands.
Sera of 97 consecutive transplant patients were
studied for the presence of antibodies directed
against antigens in renal allografts, using anindirect immunofluorescence technique. A highly
significant correlation (p <0.001) was found be-
tween irreversible rejection and donor—specific
endothelial antibodies (EA.b). The EAb are proba-
bly responsible for the rejection process for the
following reasons: 1) histological changes are
present in the vessels of the graft; 2) igG can
be found by immunofluorescence along the vessels
of the graft in patients with serum EAb; 3) EAb
can be isolated from rejected grafts by acid elu—
tion; 4) accelerated acute rejection was observed
in one patient with pretransplant EAb in the ab-
sence of lymphocytotoxic antibodies. The specifi-
city of the serum EAb was studied in absorption
experiments: adherent donor spleen cells removed
the antibody activity, whereas non—adherent donor
spleen cells, pooled platelets and erythrocytes
had no detectable effect on the EAb. Direct evi-
dence for the monocyte—specificity of EAb was
obtained when EAb positive eluates were studied;
the antibodies reacted only with the monocytes
from a panel of leukocytes. Positive reactions
did not correlate with the HLA—A, B, C, Dr anti-
gens from the cell donors.
From this study we conclude that the target of
vascular rejection can be localized on the endo—
thelium of the renal vasculature. Part of the
rejections are based on a husnoral immune response
directed against non-liLA-A, B, c, DR antigens
present on araft endothelium and monocytes.
PROL.4CTIN IN CHRONIC RENAL FAILURE (CRF),HAE
MODIALYSIS (HP) AND TRANSPLANT PATIENTS (RT)
R.Peces,S.Casado,M.Frutos,C.Horcajada,J.M.L6pez
Novoa, L. Hernando.
Fundaci6n J imnez Draz,Madrid, Spain.
Basal serum levels of Prolactin (P)and after sti
mulation and suppression with TRH and Bromocriptine
(BR)1 were measured by RIA in 9 non dialyzed patients
with CRF (pre—HD)in 21 haemodialyzed patients(HD),
in 12 with functioning renal transplant (RT) and compa
red with 11 adult healthy controls (C). Data from ma
les and females were analyzed separatelly. Pre—HD and
HD male patients showed basal levels significantly hi
gher than controls (C:5.57 1 .26, pre—HD: 27.98 +
6.18;HD: 17.75 3.65 ng/ml; S.E.M.p 0.025)
After TRH injection pre—HD and HD patients showed a
smaller stimulation than controls (C: 535 + 204%,
pre-HD:A 82.2 19.6%; HD: 75.0 28.l%;p <
0.05).The higher increments was observed at 15 mm
in controls and at 60 mm in patients. After BR test
the suppression was smaller in pre—FID and HD,when
compared with C (C: -73.3 7.6%;pre-HD: -48.
7.9%; HD:1 -34.4 + 7.5%;p.O.OS).
Basal levels of P in RI were not different from
the controls.After TRH, the stimulation is only higher
significantly at 120 mm compared with C. The suppre
ssion test gave a response similar to the controls one.
Women had a basal value higher than men. The high
basal values of P and the blunted response to stimulo
tion and suppression in CRF1 suggest a decreased renal
catabolism and/ar impaired control of it secretion.The
maintenance of high P levels after TRI—l in RI suggest
a decreased catabolism1 may be mediated by the steroid
PROTECTIVE EEEECT OF DIURETICS IN GENTAMICIN
INDUCED NEPI{ROTOXICITY
J. Petersen, P.H. Whiting, d.G. Simpson (Intr.
by N. Edward)
University of Aberdeen Medical School, Scotland.
Gentamicin (G) is known to be nephrotoxic in
man and animals. It has been suggested that this
toxicity can be potentiwied by other drugs
including frusemide.
We have studied the nephrotoxicity of G alone
and in combination with three high ceiling
diuretics, frusemide (F), bumetanide (B) and
piretanide (P) to determine whether nephrotoxic
enhancement occurred.
Male ME1 mice (42—56 days) were injected
mntraperitoneally with either G 100 mg/kg alone
or concurrently with F 5 mg/kg, B 0.5 mg/kg or P
I mg/kg, daily -for 0 days. Urinary N—scetyl—B—
D— glucosaminidase (NAG) excretion was measured
dai ly 8 hours after inFection.
Bilateral nephrectomy was carried out on half
the animals in each group on the tenth day, and
renal tissue examined by light microscopy,
histochemical ly and by electron microscopy.
G alone produced a graded increase in urinary
NAG excretion with a peak on the seventh day of
treatment; values returned to the normal range
before the end of the dosing period. The
combination of 0 and diuretic prevented this
trend. With light microscopy there was no
difference between the groups.
We conclude that these potent high ceiling
diuretics given concurrently with a nephrotoxic
dose or C do not enhance but may protect against
3 induced nephrotoxicity in mice.
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CARDIOTI-IORACIC RATIO (CTR) AS AN INDEX OF
BODY FLUIO BALANCE IN PATIENTS UNDER ROT
A. Poggi and Q. Maggiore.
Centro Fiaiologia Clinica CNR, Reggio Ca—
labria, Italy.
In patianta under ROT the estimatiun uf
"dry" weight for the maintenance of water—
sodium balance ia largely empirical. To as
aesa the value of CTR aa an index of the
body fluid balance, we measured in 26 pa-
tients (pta) the CTR variations occurring
during the interdialytic intervals and re-
lated them to the concurrent changes in
bw and arterial pressure (AP). The % in-
crease in CTR during the intardialytic in-
tervals correlated to a highly significant
degree with the % increase in bw (OCTR=
3.65+1.66 bw; r=.58; p < .01). AD vans
tions did not correlate significantly with
bw changes.
Four pta with markedly increased heart
size were submitted to progressive body
fluid removal aiming at a CTR below .50
as an end point for the achievement of the
"dry" bw. After varying periods of ROT,
CTR decreased 12.6—24.6% and bw 6-10.5%,
while AP remained within the normal range.
We conclude that CTR provides a valuable
guide for the achievement of the optimal
fluid balance, expecially in the patient
whose blood pressure does not sense body
fluid retention.
OXALIC ACID CONCENTRATION IN SERUM MEASURED BY
ISOTOPIC CLEARANCE TECHNIQUE. EXPERIENCE IN HYPED—
AND NORNO—OXALURIC SUBJECTS.
J.A.C. Prenen, E.J. Ucrhcut Noes, P. Beer, H.J.
Endesan, tK.H. Ephralm
University Dospi t1l , Utrecht , The Netl,erloods
We performed I J labeled oxslic acid IDA)
clcsrance atudiea in a mother and 4 children, one
of whume had cild renal failure caused by biopsy—proven cxsloaia. From the OA clearances and che-
mically determined urInary OA, the serum OA Ic—
yls could he calculated. Recovery of the infused
C—activity (which was all within the oxalate
fraction) with the urine was 87—I 12%. Biologicalt was inversely related to the clearance values.
Serum OA levels in the 3 normal sub ecta were ÷ 10
times lower than those reported with chemical me-
thods. One girl also had hyperoxaluria and glycol-
aciduria, but normal renal function. Her serum OAlevel was elevated, but not as much as in the
brother with renal impairment. The OA excretion
and serum level of the latter decreased after
vit. B treatment. The results were;
age 1se urine OA klesrance OA C IC 'serum OA
I I I OA creatppgpjIL.45 e 9 175 2.24 0.9
25 i' 5 246 1.16 0.1
18 d' 123 47 1.88 16.3
after therapy 55 17 1.88 5.1
5 o 30 219 2.63 0.8
13 106 209 1.80 3.4
Itis concluded that available direct methods
for serum OA determination are unreliable, and
that conclusions based on them (e.g. regarding
effect of dialysis) are invalid. Serum OA levels
are devoted long before renal impairment occurs,
and can be used as a guide for treatment.
TREATMENT OF NODERATE TO SEVERELY HYPERTENSIVE
PATIENTS W1TH AN ORAlLY ACTIVE CONVERTINO—ENZYML
iNHIB1TOR.
E.J.L. Prins, A.J.M. Oonker, F.H.H. Leenen,
O.K. van der Hem.
Department of Nephrology, State University of
Croningen, The Netherlands.
Captopril, a potent orally active inhibitor of
converting—enzyme, was administered to moderate
and severely hypertensive patients. Prior to
hlockade of the renin—angiotensin—aldosrerone
axis by this new compound, renal function snd sen-
sitivities to exogenously administered angioten—
sin I, angiotensin II and hradykinin were deter-
mined.
All patients showed a sustained fall in blood
pressure during the blockade, some patients only
after addition of a diuretic. Untoward effects
were n'ot observed. Plasma renin activity in —
creased, plasma aldoaterune concentration de —
creased. Glomerular filtration rate and effective
renal plasma flow were preserved or increased.
The pressor effect of exogenously administered
angiotensin I decreased during captepril treat —
ment; on the contrary the sensitivity to exoBe000s
bradykinin increased markedly.
It is concluded that converting—enzyme blockade
seems to be an acquisition to the treatment of
hypertension. Secondly, the increased sensitivity
to bradykinin during converting—enzyme blockade
may be at least so important as the decreased
formation of angiotensin II in the explanation of
all effects of this new antihypertensive agent.
PLATELET HYPERSENSITIVITY IN
THE NEPHROTIC SYNDROME.
0. Remuzzi, 0 Marchemj, C. Mecca, C • de
Caetano, M.J.Silver.'
Nephrolngy Divimion Oapedali Riuniti, Serga-.
mo, "Mario Negri" Institute, Milan, Italy;
3ardeza Foundation,Philadelphia, U • S. A.
The relationmhip between low levels of
circulating plasma albumin and hypersensiti-
vity to the induction of platatat aggregation by
arachidonic acid (AA) wam studied in 11 pa-
tientm with nephrotic myndrome (NS). Ten
healthy volunteers acted am controls.
The rationale for this study is that albu-
min may regulate platelet aggregation binding
AA, the substrate tor prostaglandin and
thrombnxana synthesis by platelets.
The mean thremhold concentration of AA
necessary to induce aggregation in patients'
platelet rich plasma wam 0.15 mM while this
value for normals was 0.53mM (P.10.001),
In 3--cases addition ot albumin to the patients'
platelet rich plasma to raise the plasma albu-
min level to the normal range reaulted in nor-
malizing the threshold aggregating concentra-
tion (TAO) to AA, lnfusiona of albumin to 2 pa-
tients reaulted in normalization of TAO to AA.
The data indicate that the low plaama albu-
min concentration in patients with NS is an
important factor in their hypersensitivity to
platelet aggregation in vitro and probably
contributes to their thrombotic tendency.
HUMAN GM1MA GLOBULIN ENHANCES THE SURVIVAL OF
RENAL ALLOGRAFTS
R. K. Riggio, J. S. Cheigh, W. 0. Stubenbord,
N. Suthanthiran, M. Fotino, R. Haschmeyer,
K. H. Stenzel, and A. L. Rubin
Rogosin Kidney Center, The New York Hospital —
Cornell Medical Center, New York, New York
Human gamma globulin is under clinical in-
vestigation as an immunosuppressive agent for
use in renal transplantation. This report
details our experience with an intravenous
formulation, recovered from maternal source
blood (RPGG), in a prospective study now 31
months in progress. Adult recipients of 1st
and 2nd cadaveric grafts were randomized to
either a treatment (50 patients) or a control
group (46 patients). Both received standard
immunosuppressive therapy; the treatment group
also received 68 grams of RPGG over a 4 month
period. Comparison of the groups revealed no
significant differences in composition for the
following parameters: Total HLA mismatches,
H—locus mismatches, preoperative blood trans-
fusions, and immunization Status (i.e. responder
or non—responder). The two year survival rate
of grafts was found to be increased by the use
of RPGG; from 32% to 55% for 1st grafts and
from 25% to 51% for 2nd grafts (pO.O3). The
beneficial effect of RPGG was clearly evident
in both the preimmunized recipients (RPGG Group
74% vs. 41% for the control, p=O.O5) and those
who had received blood transfusions (RPGG Group
68% vs. 31%, pO.Ol).
These data, coupled with similar results
previously reported with an IN protocol for
RPGG, lend further support to the graft—enhancing
properties of this human biologic preparation.
FACTORS RESPONSIBLE FOR THE FUNCTIONAL
PATTERN OF THE CADAVERIC KIDNEYS STORED UP
TO 25 HOURS BEFORE TRANSPLANTATION
W. Rowiuiski, L. Gradowska, D. Rowiska,M.Lao
.1. Walaszewski, J. Szmidt, J. Nielubowicz,
T. Orlowski. Institutes of Transplantology
and Surgery, Warsaw Medical School, Surg.Res.
Lab Pol. Ac. Sci., Warsaw, Po),andhe aim of the present studies was to
evaluate the possibility of determining pros-
pectively what may be the safe cold storage
time of kidneys taken from the heart stand—
—still cadavers for transplantation.Functio—
nal pattern after the transplantation of 110
cadaveric kidneys stored in simple hypother-
mia for up to 25 hours was analyzed in rela-
tion to* age of the donor, extent of preago—
nal kidney damage, the lenght of warm, cold
and standardized ischemia times and the micro-
scopical evaluation of the kidney biopsy taken
after revascularization.
Analysis of various factors showed that
the most important for the functional pattern
after transplantation have been preagonal
damage and the ratio of the total I warm
ischemia time. Basing on that observation the
nomogram has been proposed which allows for
calculation of the safe cold storage time
after harvesting of the kidney.
SERUM IMMUNOREACTIVE TRYPSIN IN RENAL
DISEASE
K.W.Rumpf, H.KoOp, F.Stöckmann, P.G.Lan—
kisch, F.Scheler
Department of Medicine, University of
Gättingen, West Germany
Trypsin is largely eliminated by fecal
excretion in normal man, Significant
amounts of the enzyme are detectable in
serum by RIA techniques. Although renal
excretion is minimal (Gut 19,A96o,1978),
the kidney may be of importance in the
elimination of the enzyme. METHODS:Serujn
iinmunoreactive trypsin (IRT) was mea-
sured (Lancet i, 66,1977) in 23 patients
on regular dialysis treatment (RDT) and
in 3o patients in the predialytic phase
of chronic renal failure. RESULTS: 1. In
the latter group IRT was directly cor-
related to serum creatinine (r=o.72; p
0.001). 2. IRT levels were elevated in
all patients with serum creatinine ex-
ceeding 4 mg/looml. 3.RDT patients ex-
hibited elevated IRT values of 994±68 ng/
ml (mean±SEM: normal range; 105—480).
4. IRT levels were not influenced nei-
ther by haemodialysis nor by haemof ii-
tration. CONCLUSIONS: The results are of
physiological and clinical interest:
1. Raised serum IRT levels in chronic re-
nal failure indicate that the kidneys
play a major role in the elimination of
trypsin. 2. Acute and chronic pancreati-
tis are not rare in chronic renal failure
the estimation of IRT is not helpful in
the diagnosis of these often fatal com-
plications.
PROLACTIN, GROWTH HORMONE, THYROTROPIN, INSULIN,
C-PEPTIDE, GLUCOSE TOLERANCE ANt) PITUITARY-GONADAL
AXIS IN PATIENTS WITH COMPENSATED RENAL FAILURE.
G.Schernthaner, H.K.Stummvoll, J.Spona
Dept.Med.II,Dept.Gyn.I,Univ.of Vienna, Austria
Conflicting data exist regarding disturbances in
the endocrine system in patients (p) with compen-
sated renal failure (CRF). Therefore we studied
concentrations (c) of prolactin (PRL), growth
hormone (GH), and thyrotropin (TSH) following TRH
(2ooxg) administration as well as the c of the
follicle stimulating hormone (FSH) and luteinei—
zing hormone (LH) after LH-RH (5ojig) application
in 12 male p with CRF (mean age 38,6yrs.,mean
serum creatinine 4,Gmg/dl) in comparison to 18
age matched healthy men. In addition c of C-pep-
tide (IRCP) , immune reactive insulin (IRI), GH
nd glucose were measured after an long oral
glucose load in all patients and controls.
Results: a)basal c of LH,FSH,PRL and IRCP were
significantly increased, basal c of testosterone
significantly decreased, whereas basal c of TSH,
GH, IRI and 17-8—estradiol were normal.b)The
maximal response (umax) of LH,FSH,PRL and GH
following 5oig LB-RH and 200pg TRH did not differ
between the patients and controls. c)TRH induced
TSH release was significantly diminished. d)The
decline of PRL,TSH and GH was significantly im-
paired. e) Glucose c were significantly increased
following oral glucose load. f)IRI was significan-
tly elevated only in the late phase of the OGr,
whereas IRCP—c as well as the molar IRCP/IRI/ratiO
was significantly increased at all times of the
OGTT.g) lack of suppression of GM by OGTT.
These data show that various endocrine and meta-
bolic changes exist even in patients with compen-
sated chronic renal failure not on hemodialysis.
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PEPTIDE HORMONES: A COMPARISON OF RENAL
HANDLING AND DIALYSIS THERAPY
E .Schlatter, H .3 .Schurek, K.Schifldhelm,
R.Zick, H.Stolte.
Med. Hochschule, Hannover, W.Germany.
For chronic renal failure(CRF)patients
suffering from diabetes the removal of
peptide hormones by dialysis (DIR) and
haemofiltration(HF) using highly permeab-
le membranes is of increasing clinical
relevance. In this study the normal renal
handling of insulin(INS) and c-peptide(CP)
as modelled in the isolated rat kidney
(recirculation, Sg% bovine albumin) is
compared with the kinetics of in vitro
DIR and HF systems (using cuprophan, CUP,
and polyacrylonitrile,PRN, membranes).
In the isolated kidney urinary clearan-
ce ratios of CP to Inulin and INS to Inu-
un were o.3 and o.1 respectively. The
catabolic clearances of both peptides
were loo% greater than the inulin clearan
ces. In in vitro DIR and HF studies CUP
was found to be virtually impermeable to
both peptides. With the PAN membrane both
peptides exhibited clearances which were
2o% of those of glucose. During HF expe-
riments the PAN membrane sieving coeffi-
cient of both peptides was 0.2.
By normal renal handling INS and CP are
not only removed by glomerular filtration
and tubular reabsorption but also by
peritubular uptake and secondary catabo-
lism. The removal of INS and CP by PAN
membranes from CRF patients is low in
comparison with renal catabolism, but has
to be taken i0to ccouOt for the DIR the-
rapy or uraemtc diabetacs.
CADAVERIC RENAL GRAFT ACCEPTANCE WITHOUT
AZATHIOPRINE (AZA)
P.Schmidt,H.Kopsa,P.Balcke,J.Zazgornik,P.Pil s
1st Med.Clinic,University of Vienna, Austria
The favourable course of 1 transplant patient in
whom AZA was omitted because of drug induced
cholestasis encouraged us to withdraw AZA in 6
further cases with good kidney function (mean
serum creatinine(Scr)1.5(O.8—2.3)mg p.c. despite
mismatched antigens(2C—,1D-,4E—matches). The
cause of stopping AZA was liver injury in 4,
leucopenia in 1 and infection in 2 cases 33.7
(O.8—75.6)months on average after surgery. In all
patients usual schedule of prednisolone therapy
war not changed. In 5 cases Scr remained stable
during a mean observation time of 14.3(1.6—26)
months, 2 of them showing moderate reversible
rejection during follow up. In 2 further cases
with rejection(1 fully, 1 partially reversible)
AZA was replaced 3.0 and 5.7 months respective-
ly after withdrawal.
In 6 patients with chronic rejection and
progressive transplant failure AZA was omitted
because of haematological reasons. 5cr values of
these cases were plotted semilogagainst time.
Rise of Scr in 5 out of 6 cases showed a linear
behaviour, so that time of terminal graft failure
was predictable. Despite AZA withdrawal at a Scr
of 5.0(3.2—6.9)mg p.c. the slope of the curve
remained unaltered.
The data show that omission of AZA may be
compatible with good long-term graft acceptance.
Chronic rejection therapy without AZA may not
necessarily accelerate deterioration of
transplant function.
HAEMOFILTRATION (1W) — CRITICAL EVALUATION OF CLINICAL HENEFITS
H. Schneider, C. Streicher, Katharinerdiospital Stuttgart , FRG
ldth the experierme of 3 years' chronic HF and nearly 4000 treat-.
rents in 17 patients we accomplished a critical survey and comparison
with the preceeding 3 months— 7 years period of conventional dialysis
(HO).Postdilntion HF was carried out 3x weekly with an exchange vol-
ume of 20I.Heriatocrit (Mci) values did not change consistently. Pre-
treatment values of small molecular uremic salutes increased 19 —39%
(HUN +19Z,creatinlne +9.8%,uric acid •f25.8%),inorganic phosphate and
inguested aluminium hydroxide +4.2 respv4-30%, total serum Ca de-
creased 7Z.No significant radiological signs concerning development
or deterioration of renal osteopathy were detected, yet P18 levels Im
creased from in mean 84 36 to 198 96 pmol/L, VIt.D levels
stabilized within normal limits. Fat metabolism was studied in control
periods with use of lactate—., ncetate—,end bicarbonate buffer. Com-
pared to the preceeding HI, HF did not influence hypertri—
glyceridemia, the different buffer sebstances exiiibited no signif I—
cant influence on triglycerides. tabolic acidosis was corrected
ineffectively by lactate, better by acetate and nearly compensated
by bicarbonate buffer (33.75 req/I each). Serum levels of middle
eolecuiar substances determined by sephadex chromatography declined
in mean 50%, correlated to clinical Improvement of neuropathy and
motor nerve conduction velocity in 5 of 7 patients with distinct
polyneuropathy. Thyroid hormones continously decreased (TSH , 13 ),
Thyroxlne—binding—qlobulirw (JIG) values were subnormal. 13, 14 and
TSR were not detectable in filtrate samples. 14/IBG ratio Heclined
from 3.05 .' 1.10 to 2.44 0.74 (normal range: 2.5 — 3.9),indlcating
development of peripheral hypothyroidism. 2 of 8 patients with
dialytic resistent hypertension exhibited no improvement and had to
be nephrecteaized. 6 patients responded and antihypertensive drugs
could be markedly reduced. Dopaaine—U—bydroxylase (DIR) plasma
activity was subnormal In hypertensive (19.3 21.2 I.U.) and norms—
tensive patients (26.5 31.4 1.8.) and revealed a slight trend to-
wards increasing values under long tern HF (21.7 * 20.7 1.8. and
335 36.3 1.1. resp.). Intraindividual comparison of symptoms of
dialysis discomfort exhibited diminished symptoms in HF us opposed to
HO as a result of less fluctuation in serum osmolality and increase
of peripheral resistance induced by significant elevation of 088
levels.In conclusion HF improved polyneuropathy and volume — sodium
dependent hypertension untractable by conventional dialysis without
major symptoms. HF was found to be ineffective concerning improve-
ment of Hct, hypertriglyceridenla and prevention of renal osteopathy.
CENTRAL AND PERIPHERAL HEMODYNAMICS IN LONGTERM
PERITONEAL DIALYSIS (PD) PATIENTS.
R.Sëhuriq, M.Schartl, H.Becker and G.Gahl
Dept. of Nephrology and Cardiology, Klinikum Char-
lottenburg, Free University Berlin.
Longterm PD is especially recommended for patients
with advanced cardiovascular disease. Still only
few and controversial data are available on the
hemodynamic effects of PD. Therefore a study was
undertaken to evaluate the acute hemodynaniic ef-
fects under PD. 9 patients (mean age 58 y),
which were under longterm PD for 1—14 months,
were studied.
Studies were performed during one PD with a Swan-
Ganz-catheter. The following parameters were mea-
sured: cardiac index (CI), pulmonary artery pres-
sure (PAP), right atrial pressure (RAP), central
venous pressure (CVP). Total peripheral resistance
(TPR) and stroke volume index (SVI) were calcu-
lated. Arterial blood flow (ABE) and venous capa-
city (VC) of the extremities were measured using
venous occlusion plethysmographic technique. Mean
arterial pressure (MAP) and heart rate (HR) were
also recorded.
+
Mea pre-PD CI (3,9-0,5), SVI (47±6) and HR
(8313) were normal . Pre-PD PAP was elevated(21—18 mmHg). MA: was 105 mmHg. Mean weight loss
during PD was 1,6 kg. The most striking post-PD
hemodynamic changes were a signif. 20% decrease
of CI and a 17% decrease of PAP. HR and MAP re—
iiained unchanged due to a 25% increase of TPR.
CI, TPR, CVP, PAP, HR and MAP were unchanged after
filling the abdomen with 2 1 of dialysate. ABE
was stable, whereas VC decreased by 20%. These
results confirm our previous clinical experience
that PD is generally tolerated without serious
hemodynamic side effects.
EFFECT OF RESIDuAL RENAL FUNCTION ON MINIMUM
OIALYSIS REQUIREMENTS
B.H. Scribner, A. L. Bahb, J. Milutinovich
University of Washingtce, Seattle, WA, U.S.A.
To demonetrate that email amounts of residual
cenal functice (ORE 1.0-4.0 ml/min) can maintain
henodi alysis patients free of neuropathy despite
marked shortening of dialysis time, 6 patients
with stable OFR's >1.0 mi/rain were selected for
prospective study. These subjects were placed
ma a short time thrice-weekly dialysis protocol
while keeping the dialysis index for middle
molecules (OIEN) >1.0. Oieiysis time was reduced
from 12-24 hr/wk to 5.0-9.9 hr/wk. Over the
Pxperimantai period of 1.2-4.1 years SUN levels
rose fran 67 to 91 mg/dl and creatinine levels
from 10.1 to 13.0 mg/dl. All 6 patients remained
well and without any new criaplications. Hemato-
crit fell in some end increased in others. There
were no significant changes in the SNCV. In
additimo, all maintained stable dry weight and
reported an improved sense of well-being. Three
additicoal patients whose Oij(MM) was allowed to
fall to the 0.6-0.8 range as their ORE declined
developed significant slowing of the MNCV, and
one developed sensory symptoms end temporarilylost his ankle jerks. When the DI(MM) was raised
slightly above 1.0 by switching to a rreobrane
permeable to middle molecules, all neuropathic
symptoms disappeared and improved. We postulate
that the protection afforded the first 6 patients
is due to the ability of the residual nephrona to
excrete neurotoxic middle molecular weight sub-
stances. Recomsandation: Only anuric subj ects
should be used to evaluate any new dialysis tech-
nique, i.e., hemoperfusion, whose primary diffen-
ence is increased middle molecule removal.
VASCULAR STABILITY DURING HIGH—FLUX HAEHOFILTRA—
TION (HF)
S. Shaldon, 0. Oeschodt, H.C. Beau,. Clsret,
H. Mion, and C. Mba
Dept. of Nephrology and Biochemistry, University
Hospital Nimes, and A.I.O.E.R. Montpellier, France.
Symptomatic hypotension (SH) has been reported
to be less frequent during post dilutinnal HF than
hsemodialysis (HD) and is explained by lesser serum
osmolality changes (tOsm) and intercompartmental
volume shifts due to lower urea clearance (CU)
with HF. The 5dvent of a high—flux post—dilution
haemofilter (Amicon 1.3m2) permitted us to com-
pare drop in blood pressure (AMAP), arterial oxy-
gen tension 4A02' intratreatment weight loss
% haematocrit increase (AHct), drop in se-
rum osmolality (ADam/kg) and urea (durea,m,mol/L)
during 4 hr HO and 4 hr 4F with similar CU (HO CU
140± 4 ml/min: HF CU 137— 5 ml/min) and acetate as
replacement base in both in 3 selected patients
with SH during HD.
The results expressed as mean± SEN were:
AMAP APAO2 ABW A.Hct osm Urea
mmHg mmHg kg 1 1kg m.mol
HO 32±8 16±6 2.4±0.3 23±8 21±4 20±4
HF 5±2 20±7 2.3±0.4 25±10 19±4 19±3
p 0.01 NS NS NS NS NS
Oespite similarity in weight loss, hypovolae—
mis, hypoxsemis, changes in urea and osmolslity,
and an equivalent maximal increase in serum aceta-
te (HO, 5 m.mol/L: HF, 4.9 m. mol/L), decrease in MAP
was significantly loss with HF. Whilo SH is mul—
tifactorial in origin, these results suggest a
fundamental difference between HO and HF not exp—
plsined by any of the measured parameters. One ex-
planation could be that HF permits a more appro—
proate response of peripheral resistance to hypo—
volsemia in spite of multifactorial opposition.
PLASMA SEPARATION IN OCXDOPASTUBE' S SYNDROME AND
MULTIPLE MYEIOMA
H.G. Sieberth, N.M. Glbckner
Msdizinische UniveraitHtaklinlk of Colpane,
Germany
In a patient with Gacxdpaature' s Syndroras and
two patients with multiple myelorrn and kidnoy
insufficiency 18 plearraseparations were per—
forced with a new cellulose diacetate hollow
fibre nodule (Itdul ARE Asahi Wedical Co.
'Ibkyo). The rasthod was alroady described core
in dtai1 (Proc. Eurpa. Soc. Artif. Org.5,214,
1978). During ohne troatiaont inbetween 90 mm.
approximately 5.000 ml of plasma wore separated.
The surface area of the nrxlule was 0,65 m2, pore
size 0.2 pm and the cutoff at 3.000.000 Oaltons.
The protein content in the separated plasma was
60 % of that in bloodplasata. After three plasma—
separations in the anuric patient with Good-
pasture's Syndrome the antigloaerular basesent
neabrane (GEM) antibody titer was deminiahod
from 46 % to below 3 % (normal range - PTA, P.
Nahieu, Lidge). Severe pulmonary haosorrhaga
disappearend after 24 hours. Under iimminauppres-
siva therapy the anti GEM Pntibedy titer could
be kept down, but kidney function did not ini-
prove. In the patients with Multiple Myeloma
gasmsa globuline concentration was deminished
during one separation for 20 to 25 % of the
initial concentration. then the gamma globuline
concentration was deminished from 3.2 g/100 ml
to 1.1 gIbe ml it lasted in cytostatically
treated patients approximately 6 weeks until
the initial concentration was reached again.
An ingoroverasnt of kidney function could not
be observed up to now in these patients.
ULTRAVIOLET PHOTOTHERAPY IN URAEMIC PRURITUS
N B Simafl and A N Osvison. Oepartaents of
Oermstology and Renal Medicine, St James's
University Hospital, Leeds, UK.
It has recently been reported that ultraviolet
photothorapy is effective in relieving ursenic
pruritus (Oilchrist et al 1977). We have assess-
ed this treatment in a double—blind cross—over
study using an ultraviolet B source (UVB), and
for control an ultraviolet A source (OVA) which,
at the dosage employed, is devoid of biologicml
effect. 10 patients (7 males, 3 females) who
had been on dialysis for 3 months to 11 years
(mean 3.7 years) and who were considerably in-
convenienced by pruritus were studied. The sev-
erity was indicated by the patient marking a
10 cm line which was graded for pruritus from nil
tn totally incapacitated. Treatment was twice
weekly and commenced with a sub—erythema exposure
to either UVB or OVA (approx 1 sin). The patients
were unaware which UV source was being given.
Exposure time was gradually increased to spprox
20 sin and after 4 weeks the patients were cross-
ed—over to the alternate UK source. The degree
of pruritus was assessed by the patients at week-
ly intervals without reference to their previcus
score. With both active sad placebo ultraviolet
therapy the severity of pruritus diminished equsl..
ly. The conclusion of this study is that ultra-
violet B light is not effective in ursesic pruri—
ins and tint patient's response probably indica-
tes a placebo effect.




EXPERIE3E IN CPDAVERTC KIDNEY REITRANSPLIINTATION
t'LJ.H. Sicoff, A.M. Tegzess, S. Neijer,
R.A.F. Krcei, W.P.L. van Haven, G. Kcotstra (Intr.
by G.K. van der Hem)
State University Groningen, University Hospital,
IDept. of Surgery, The Netherlands.
The results of retranspiaStations with cadavoric
kidneys are considered to be 1x)or. In view of the
ehortage of donororgans their use for rdttans—
plantation can be questioned.
A retrospective study has been perforned on
44 patients with a failed first cadaveric graft
who received a second cadaveric graft between
January 1972 and January 1979. A control group
of 149 patients receiving a first cadaveric graft
in the sane period was established. Post operative
tnanageirent and inniunosuppressive treatirent were
the sane in all patients.
Survival rates are computed by actuarial
trethods.
%\ao year patient and graft survival after
second cadaveric kidney transplantation are
respectively 82% and 36% compared to 89% and 55%
in the control group.[\o year graft survival after second trans-
plantation in patients whose first graft failed
due to ngr gpl ical reasons (N = 15) is60%
ccepared to 20% in patients whose first graft
failed due to irmiunological reasons (N =29)
(p(0,0l)
The presence or absence of cytotoxic antThodiis
at tine of the second transplantation did not in-
fluence graft survival after the second trans-
plantation (p> 0,10).Oii account of these figures the use of scarce
badaverdonor kidneys for second transplantation
in patients with an iniminological first cadaver
graft failure is hardly justified.
HAEMODIALYSIS IN SCHIZOPHRENIA
G.Sjjgi,V. Bruno, F. Dc Meo, F. Ferio
zi, M. Cammà, P. Pomero.
S. Salvatore Hospital, L'Aquila, Italy.
13 schizophrenic patients, 18 to 28 years old,
with symptomps dating from 3 to 6 years, were
haemodialyzated. Pharmacological treatment
was not modified during haemodialysis. Polycry
lonitrilic dialyzers 1 m2 were utilizeJ . The
vascular access was obtained slipphg into the
femoral vein a Shaldon catheter connected to a
double pump for single needle. Each patient was
treaded iritially by 3 hours haemodialysis for3
days consecutively repeated after 2 weeks and
successively every 3 weeks. During 6 months
the results have been evaluated clinically and
by Overall and Lorr scale. In I hebephrenic
schizophrenic patient no improvement was obser
ved. After the second cycle the treatment of 2
patients was suspended for non medical reasons.
Satisfactory results in 7 patients who showed
marked attenuation of the most evident signs of
schizophrenia (autism, delirium, allucinations,
flatness of affect) were obtained. In the remaic
ning 3 patients complete disappearance of the
psychiatric symptomatology was observed, with
reintegration into their normal working activi
ties.
DETECTION OF MEMORY CELLS BY CHEMICAL MODIFI-
CATION OF THE CELL SURFACE.
K.H. Stenzel, M. Suthanthiran, A.L. Rubin, and
A. Novogrodsky. Rogosin Kidney Center, The New
York Hospital—Cornell Medical Center, New York,NY
Included in the repertoire of alloantigen—
induced immune responses are the generation of
cytotoxic T cells (CTL) and memory cells with
rigorous specificity for the original priming
stimulus. The lymphocyte mediated cytotoxicity
assay is currently utilized to detect circulating
CTL in recipients of allografts. However, the
stringent requirements for alloantigens for the
differentiation of human memory cells into speci-
fic secondary CTL has thus far hampered the de-
tection of circulating memory cells. We now re-
port that such alloantigen requirements can be
bypassed and memory cells can be detected by
modification of their nell surfaces with neur—
aminidase (NA) and galactose oxidase (GO).
Treatment of memory cells generated in a long—
term primary mixed lymphocyte cultures with NAGO
(NA 50 units/ml, GO 3.75 units/mi, for 30 sims at
37°C) resulted in the generation of specific
secondary CTL. Memory cells treated with NAGO
exhibited significantly greater cytolytic ac-
tivity (specific chromium release 486% of control
and total lytic activity 1071% of control). In
contrast, treatment of unprimed lymphocytes
failed to induce the generation of CTL despite
extensive blastogenesis induced by such treat-
ment. Thus, memory for major histocompatibility
complex gene products can be unmasked even in the
absence of original priming alloantigens by NAGO
treatment. Such an approach might be exploited
to detect cellular presensitization in aliograft
recipients.
CHRONIC AMBULATORY PERITONEAL DIALYSIS (CAPD) FOR
END-STAGE RENAL FAILURE (ESRF).
N.M. Thomson; R.G. Walker; 6. Whiteside; 0. Scott;
R.C. Atkins.
Prince Henry's Hospital, Melbourne, Australia.
CAPD has not met with widespread acceptance be-j
cause of a high incidence of peritonitis. We re-
port our experience with CAPD in 17 patients with
ESRF and compare with conventional intermittent
peritoneal dialysis (IPD) performed in 56 patients.
Chronic indwelling peritoneal catheters (Tenckhoff,)
were used in all patients. CAPD was performed with
2 litre exchanges introduced every 4 hrs(8 hrs cver-
night). IPD was undertaken thrice weekly (total of
100—120 litres) using either bulk dialysate drain-
age or an automatic peritoneal dialysis machine.
Both groups were comparable in age, sex and Ufl4
derlying renal disease. The mean period on CAPD
was 3.6 months (range 1-5 months) and on IPD - 7.2
smnths (range 1.5-46 months). No significant dif
ference in serum creatinine, urea and haemoglobin
concentration was seen between the groups. CAPD
allowed more liberal fluid and salt intake. A
strong patient preference for CAPD was seen. Home
training was considerably easier with CAPD. The in-
cidence of peritonitis (abdominal pain andcloudy
dialysate with polymorph exudation) was 3.8 epi-
sodes/year on CAPD and 1.4 episodes/year on IPD.
Peritonitis led to 2 deaths on IPD but none on
CAPO. Two patients with recurrent peritonitis on
CAPD were transferred to haemodialysis. Hypopro-
teinaemia was not a significant problem with
either technique.
It is concluded that CAPD is an effective form
of PD with advantages over IPD provided strict
attention is given to the prevention of peritoni-
tis However th icidence of peritonitis is
still twice tat in IPD.
STUDY OF TRACE ELEMENTS IN THE PATIENTS WITH CHRO-
NIC RENAL FAILURE BY NEUTRON ACTIVATION ANALYSIS
Y.Tsukamoto, S.Iwanami*, F.Marumo,(Intr. by K.
& Radiol.Med.*,Kitasato Univ.,
Sch.Med., Sagamihara, Japan.
Trace elements of red blood cells(RBC),hair and
finger nails were measured in 10 undialyzed(CRF)
and 9 dialyzed(HD) patients with chronic renal
failure and 10 healthy volunteers ,whereas we pre-
viously reported plasma trace elements in these
pts(VII Int.Cong.Nephrol.,Montreal). Trace eleme-
nts, Si,Ca,Mn,Co,Ni,Zn,As,Sr,Sn,Se,Br and Rb, we-
re measured by the neutron activation analysis.
Co content of NBC in CRF pts(0.ll±O.67Pg/ml)
was higher than that of control(0.032±0.018,p<0.—
02).Sn content was higher in both CRF(0.58±O.3Eug
/ml,p<O.05) and HD(O.62±O.33,p<0.Ol) pts than th-
at of control(0.23±O.l3).However,Sn content in
hair was lower in CRF pts(O.24±0.13ppm,p<0.05)
than control(1.2l±l.Ol) .Diiration of hemodialysis
negatively correlated with Sn content in RBC(r-
O.59,p<0.Ol),and positively with Mn(r=0.53,p<O.05
).Zn content of hair in both CBF(O.)4)4±0.28ppm,p<
0.01) and HD(l.)41±l.0l,p<O.05) pts were lower th-
an control()4.l5±3.16).Ca content of hair decreas-
ed in ORE pts(68±6Cppm,p<O.05) compared with that
of control(261±222),while it did not in liD pts(
308±265).In CRF pts,Ni content of hair(O.l±0.06
ppm,p<O.05) was lower than that of control(0.99±
O.85),and Sr(l5±llppb,p<O.05) was also lower than
control(72±58). In nails,As content was higher in
CRF pts(lOl±69ppb,p<O.0Ol) than that of control(
)49±)42).
These results suggest that trace elements cont-
ents are disturbed in not only plasma but tissues
such as HBC,hair and finger nails in the patients
with chronic renal failure.
PRETRANSPLANT '1" CELL LEVELS AND RENAL ALLOGRAFT
SURVIVAL.
C.H.Uittenbogaart, B.Robinson, M.Malekzadeh,
A.Pennisi, R.Ettenger & R.N.Fine. Dept. of Ped.,
Univ. of So. Calif., School of Med., Childrens
Hospital of Los Angeles, California, U.S.A.
1'' cell levels were determined in 50 pediatric
patients awaiting cadaveric renal transplantation
(TX) using the sheep erythrocyte forming test.
Total rosette forming cell (TRFC) levels were
determined 3 or more times, while the patients
were undergoing dialysis. The mean pre—TX TRFC
level was calculated for each patient. The dist-
ribution curve of the mean TRFC's was divided
into equal tertiles and these were designated as
low (< 1101/rn3), medium (1101-13)43/mm3) and high
(> 13)43 m3) TRFC groups. Actuarial allograft
survival rates were statistically significantly
different in the low TRFC group, when compared
to the groups with medium and high TRFC levels
(P <0.05). The 6,12 and 18 months allograft
survival rates were 9)4 5.7%, 9- 5.7% and
9)4 5.7% for the low TRFC group, 67 12.2%,
50 13.7% and )4l 13.9% for the medium TRFC
group and 6)4 11.9%, 6)4 + 11.9% and 53 13.9%
for the high TRFC group respectively.
Based on our data, we conclude that pre-
transplant TRFC levels may be predictive of
allograft survival.
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INFLUENCE OF PLASTICISER ON DRUG METABO-
LISING ENZYMES IN THE LIVER OF PATS.
Th.UviB,H.W.Leber,A.Prenter,G.SChUtterle
University Hospital,GieSSen,FR Germany.
To elucidate potential toxic effects
of plasticiser released from PVC tubings
subtotally nephrectomised and sham ope-
rated control rats were treated during
14 d with daily i.p. injections of 200mg
diethylhexylphthalate (DEHP)/100 g.b.w.
(I) or the solvent live oil) (II)
In subtotally nophrectomised rats hexo—
barbital sleeping time (10 mg/100 g b.w.)
decreased significantly from 60.8±8 (II)
to 22±3 mm (I) indicating an accelerated
hexobarbital degradation in (I) . In
accordance with that finding the in vitro
activity of the liver for the N—demethyl—
ation of aminopyrine was 80-100 % higher
in (I) compared to (II) . Increased in
vitro drug metabolism in (I) was due to
an augmentation of both the liver micro—
somal protein content (1:132±19, 11:79.6
mg) and of the specific activity of
the mixed function oxidation system (I:
8.0+1 .3, 11:5.7±0.7 nmoles/mg protein x
mm). In sham operated animals DEHP had
no influence on the investigated para-
meters.
It is concluded that DEHP is a potent
inducer of drug metabolising enzymes,
when the renal function is impaired. In-
ducing effects of DEHP or other involun-
tarily ingested foreign compounds might
be responsible for diverging results con-
cerning drug metabolism in hemodialysed
patients.
LOW MOLECULAR WEIGHT PROTEINS AS URINARY MARKERS
OF AMINOGLYCOSIDE NEPUROTOXICITY IN MAR.
J.—P. Valette, G. Nicot, J.—P. Charmes, L. Merle,
D. Bén6vent, C. Leroux—Robert — H6pitsl Dupuytren,
Limoges, France.
Urinary iow molecular weight (LMW) proteins are
particularly helpful in detecting early tubular
toxicity (Manuel Y., Laterre E.C., in Proteins in
normal and pathological urine —Karger— Easel/New—
York, 1969, 172—187) before renal damage has pro-
ceeded to the point of producing a decrease in
glomerular filtration rate. Such a proteinuria was
studied in 12 patients treated with just aminogly—
coside or aininoglycoside and either ampicillin or
cephalothin. Proteinuria was analyzed by means of
immunoelectrophoresis, acetate cellulose electro—
phoresis, thin—layer polyacrylamide gel electro—
phoresis and sodium dodecylsuiphate acrylamide gel
electrophoresis. Urinary lysozyme, 82 microglobu—
lin (92 m) and retinol binding protein (REP) eli-
minations were measured. We observed a urinary ex-
cretion of free immunogiobulin light chains and an
increased urinary excretion of lysozyme (mean
1 S.D. = 11,0 1,7 mg/clay). The increase in urina
ry excretion of 92 m and REP was variable. These
disturbances appeared either in patients with ami—
noglycoside or in patients with aminoglycoside and
ampicillin or cephalothin. In some cases decrease
in glomerular filtration rate appeared. Proteinu—
na and renal failure disappeared a few days after
the treatment was discontinued. We consider that
important clinical information on aminoglycoside
nephrotoxicity can be obtained from repeated LMW
proteinunia studies, even if proteinuria is low.
This would allow the physician to discontinue the
treatment before renal failure.
Abstracts
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HEMODIALYSIS IN SCHIZOPHRENIA:A DOUBLE
BLIND STUDY.
J-L .Vanherweghem, P -Linlcowski, C. Jadot,J.Mendlewicz.
Hopital Frasme,flrussels University,
Brussels, Belgium.
The therapeutic effects of hemodiely-
sis was evaluated in schizophrenic pa-
tients using a double blind procedure.
20 patients were diagnosed as acute
schizophrenics according to Feighners
criteria for psychopathology.After obtal-,
fling informal consent,the patients were
randomly assigned to active hemodialysis
or sham dialysis.A washout period of 8
days was followed by active or sham dia-
lysis treatment of 4 weeks(two 5 hours
sessions/week) and evaluation of psycho-
pathology was performed regulaly in a
blind fashion using the Brief Psychiatry
Rating Scale and the Comprehensive Psy-
chopathological Rating Scale.
As of January 15,1979, 6 patients
have completed the studyAmong the four
who have active dialysis,3 showed a very
significant improvement,while the other
only had a moderate improvement.In the
two patients who underwent sham dialysis
no significant change was observed.
According to these preliminary results
hemodialysis appear to be an effective
therapeutic modality for acute schizo—
phrenia,placebo effect or spontaneous
remission being excluded by sham dialysig
controls.
DMSO TREATMENT OF RENAL AMYLOIDOSIS (RA).
M. van Rijswijk, A. Donker, J. Marrink, L.Ruinen.
Department of Medicine, State University of
Croningen, The Netherlands.
Ainyloid (A) fibrils can be dissolved by dime—
thylsulfoxide (DMSO) in vitro. In the murine mo-
del, A—deposits disappear under influence of DMSO
with coincident appearance of A—like material in
the urine. Moreover, it has been shown that in
patients with RA A—like material can be found in
the urine after one single dose of DMSO. These
observations prompted us to investigate the ef-
fect of DMSO in patients with end—stage renal
failure caused by PA.
Two patients with BA secondary to rheumatoid
arthritis showed a remarkable improvement in re-
nal function in the course of the treatment (15 g
DMSO per day for more than I year). CFR increased
from 5 to 29 ml/min and from 4 to 17 mi/mm, res-
pectively. Proteinuria decreased.
Although the initial hypothesis was to make A—
fibrils soluble by DMSO, the finding of a fall in
SAA and CRP levels to normal values suggests a
decrease in A—deposition together with the natu-
rally occurring breakdown of A—fibrils. The re-
sults in 7 patients with other types of generali-
zed amyloidosis indicate that, except for the
difference in immunoglobulin light—chain derived
amyloid and AA—amyloid, there are also differen-
ces in pathophysiological mechanisms between
primary AA—amyloidosis and secondary AA—amyloido—
sis.
The results in secondary AA—amyloidosis due to
rheumatoid arthritis however, are encouraging and
warrant further evaluation, in particular with
regard to the anti—inflammatory action of DMSO.
PRE TRANSPLANT CYTOTOXC ANTIBODIES DO NOT SEGRA-
GATE KIDNEY TRANSPLANT RECIPIENTS INTO RESPONDER!
NON RESPONDER GROUPS. F. Vincenti, W. Amend, N.
Feduska, R. Duca & 0. Salvatierra, (introduced
by Felix Brunner) Transplant Service, University
of California, San Francisco.
The significance of pre transplant lymphocyto—
toxic antibodies(LCA) in renal transplant recipi-
ents is not clear. We have evaluated the outcome
of 639 patients who underwent primary cadaver
kidney transplantation at our center between
January 1970 and June 1978 on the basis of the
highest pre transplant LCA levels. Results are





1 Yr. graft survival
1 Yr. graft survival
in transfused pts.
1 Yr, graft survival
in non transfused pts.
Conclusions l)graft survival is independent of
the level of LCA 2)graft survival is improved in
transfused recipients whether or not they have
LCA 3)patients with moderate (11-50%) or high
(51-100%) levels of LCA may form LCA even when
not challenged by transfusions t) the expression
of LCA pre transplant does not reflect on the
responder status of the transplant recipient
visa—a—vis of the graft.
ARE ERYTFIROPOIETIN LEVELS (Ep) IN UREMIC PATIENTS
ON HEMODIALYSIS (MD-PATIENTS) DEPENDENT ON THE
KIDNEY DISEASE (KD) AND THE TIME OF HEMODIALYSIS
TREATMENT (THT)?
A.J./al1e, W. Niedermayer
University Department Medicine, Kiel, Germany
Equivocal results have been reported about the
longterni development of bioassayed EP in HD—
patients and about the relation to the various
underlying KDs. This study investigates these
problems by determining the irjirnuno-detectable
EP (idEP) in HO-patients with various KDs and
different perids of THI. The results are:
1 •The Hct (20—21), the ret iculocytes (RC,
l6_20/o), and the serum iron concentration
(SI, 99—23mg1) did not change during a 6 yr long
THT, they were not dependent on the KD;
2. The idEP in individual cases ranged fron, sub-
normal to slightly increased, irrespective of the
KD, but in analgesic nophropathies the idEP was
thrice and the PC one third higher and the SI was
one third lower than that of normal
3. The idEP increased for 3 1 during a 6 yr THT
but without concomitant Hct improvement. - The
conclusions are: 1. The missing increase in Hct
in response to increasing idEP suggest a slowly
increasing accumulation of inhibitors to red cell
production; 2. HD-patients can well produce very
high levels of idEP if stimulated appropriately
e.g. by SI deficiency as in analgesic nephro-
pathies; 3. The major therapeutic aim should not
be the administration of a drug EPbut rather












C1WIDPRIL AND SALT SUBTEACTIC TO TREAT "UNCON-
TTaDLLABLE" HYPERENSIUN IN HEDThLYSIS PATIENTS.
J.P. Wauters, B. Waeber, H.P. Brunner, G.A.Turini,
J.P. Guigriard, H. Gavras.
Dept.. of dicine, CHUV, 1011 Lausanne, Switzerland
An inaporopriate. relationship between renin
and exchangeable sodium is thought to be responsi-
ble for the hypertension of patients with chronic
renal failure. Long-term blockade of the resin
system by captopril, makes it possible to test
this hypothesis. Eight patients aged 10 to 61, on
maintenance hdialysis for 1/2 to 7 years, re-
ceived captopril in 2 daily doses of 25 to 200 m
p.o. Previously, the4r blood pressure (BP) avers-
pod 179/105±6/3 (cean—SEM) pre— and 182/103±7/3
nsnHg post—dialysis, despite intensive ultrafiltra-
tion and conventional antihypertensive therapy.
Plasma renin activity (PPJt) off all antihyperten-
sive drugs ranged fran 0.71 to 97 ng/rnl/hr. The
4 patients with the highest PRA normalized their
BP with captopril alone, whereas in the 4 remain-
ing patients, captopril therapy had to be ca1e—
crented by isovolumetric salt subtraction,i.e. 1—2
liters of ultrafiltrate were replaced by 5% dex-
trose at the end of each dialysis session until
NP was controlled.After 22-6 weeks of therapy, NP
of all 8 patients was reduced to l34/767/5 nng
(p(O.OOl) pre— and 144/81±9/5 rrirNg( p).00l)post—
dialysis without a significant change in body
weight. Conclusions: Isovolurtetric salt subtrac-
tion is an efficient and well tolerated nethcxd to
rerrove an excess of body sodium. Captopril alone
or ccerbined with isovolurretric salt subtraction
normalizes blccd pressure of patients on chronic
herrdialysis with "uncontrollable" hypertension.
FYRIDOXINE THERAPY OF ADtJIIP PRIMANY OXAWSI S
E. 3. Will, 0. L. M. Bijvoet (Intr. N. S. Knapp)
University Hospital, Leiden, The Netherlands.
We have studied, on metabolic balance, two wo-
men with Type I primary oxalosis, before, during,
and after high dose pyridoxine (B6) therapy (250
mg 6—hourly. Urinary oxalate (UVox) was measured
by isotope dilution, and erythrocyte glutamic ox—
aloacetate transazninase (Moor) before and after
activation in vitro with B6. Case I (aged 26)
presented with a single recurrent renal calculus
and, a TJVox of 1.81 mmol/24 hours (normal ( 0.6).
Creatinine clearance (CrC1) was 8o mi/mm. Case
III (aged 42) had suffered 20 years with recurrent
stone disease, passing gravel daily at the time of
study. UVox was 1.71 mmoi/24 hours; CrCi 30 ml!
win. She had marked nephrocalcinosis. Urinary
calcium excretion (tiVca) was low in both cases
(1.65 sad 1.17 mmol/24 hours). High dose B6
mmediate1y reduced UVox to within the normal
range • No further calculi were passed (Case II).
UVca was unchanged. A sharp rise in E(XY was
associated with a decline in activation by added)36. On withdrawal of therapy UVox rose to pre-
treatment levels in 3 weeks (Case I), when serum
B6 and EP were still elevated. No change in
UVox occurred after 10 days in Case II. Since re-
introducing B6 responses have been maintained, for
2 years in both cases. )teai se. creatinine has
fallen from 105 to 82 poll1 (I) and 243 to 146
,unol/l (II) (representing a near doubling of CrCl
in the latter). Primary oxalosis may present in
adults without severe stone disease or obvious
-enal failure. Hypocalciuria, discordant with ox—
alate calculi, may be a clue to diagnosis. UVo.
may become normal on B6 and renal failure reverd..
Recurrent hyperoxaluria occurs when B6 and E0(YPlevels are still elavated..
THE EFFECT OF RAENODIALYSIS AT: D TDANSPLANTATION
ON AUTONOMIC NEUdOFATHY
J A Wilson, T N Yahya, A N Davison, C R Ciles.
Departments of Renal Medicine and Surgery, St
James's University Hospital, Leeds, UK.
Uraesic neuropathy involves autonomic nerves as
well as peripheral motor ant sensory nerves. This
study was undertaken to determine the effect of
both dialysis and transplantation on autonomic
neuropathy. 10 patients with severe chronic renal
failure (se creatinine)700 umols/L), 39 patients
on thrice weekly haemodialysis (I:eltec rultipoint
1.5 sq. m.4 hrs), and 20 patients after transplan-
tation (se croatinine (200 umols/L), were studied.
!utonomic nerve function was measured by heart
rate response to a standard Valsalva manoeuvre
and blood presmare rise to a sustained handgrip.
Both tests were significantly (p <,o.ooi) impaired
in patients' with chronic renal failurs when com-
pared to patients with normal renal function.
Following the institution of hrremodialysis thers
is a.slight but insignificant improvement in the
Valsalve ratio while the hand grip test improves
significantly (p<O.OO1). After successful trans-
plantation the Valsalve ratio is significantly
i.mproved compared with chronic renal failure pat-
ients (p (0.001) bu is still significantly im-
paired when compared to normal (p <.o.ooi), the
hand—grip test, however, returns rapidly tonoruai
The conculsion from this stuiy is that autonomic
neuropathy occurs in chronic' renal failure and
improves followin' dialysis and transplantation
but that the nerve fibres involved, in the baro—
receptor refle may be irreversibly damaged by
uraemia while those involved in peripheral vase—
construction seem relatively spared.
REGULAR HAEMODIALYSIS THERAPY (ROT) INDUCES A
PROTHROMBOTIC STATE
H.F. Woods and N.J. Weston, Renal Unit, Kings
College Hospital, London. (Introduced by V.Parsons
To determine whether activation of coagulation
factors and platelets, reported during haemodialy-
sis results in a prothrornbotic state we have
studied indices of coagulability in 15 undialysed
and 32 dialysed uraemic patients. Mean plasma
fibrinogen (g/l) in uraemic patients (3.53) was
significantly higher than in controls (2.45) and
rose further in dialysed patients (3.81). Factor
VIII coagulant activity (CA) was greater in
dialysed (202 + 15.9%) than in undialysed ursemic
patients (184 + 14.2%) both being significantly
greater than control (84 + 3.9%). Similarly
Factor VIII related antign (RA) was higher in
dialysed patients (216 + 18.5%) than uraemics
(156 ÷ 9.6%) (Control =94 + 5.6%). The mean
RA/CA ratio and the frequenEy of a high RA/CA
ratio (.(1.5), an index of thronbin induced con-
sumption of Factor VIII-CA and intravascular co-
agulation, were higher in dialysed than nondialy-
sed patients.
Despite the higher circulating levels of proco-
agulants and the evidence of thronibin activation
the availability of heparin cofactor-antithrombin
III (AT III) was lower in dialysed (154%) than in
uraemic patients (159%) though in both groups
AT III levels were higher than in controls (100%)
These results indicate that RDT is associated
with a prothrombotic state which is not complete-
ly compensated for by an increase in antithrombin
III.
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THE USE OF PROSTACYCLIN (P012) DURING CHARCOAL
HAEMOPERFUSION
H.F. Woods and M.J. Weston, Kings College
London
S. Bunting, S. Moncada and J.R. Vane, Welicome
Research Laboratories, Beckenham, Kent.
Although charcoal haernoperfusion has been used in
the treatment of hepatic and renal failure and of
drug and other intoxications, its potential has
been limited by thrombocytopenia and other effects
on platelet function. To try to improve blood-
compatibility of charcoal haemoperfusion we in-
fused P012, the most potent platelet inhibitor
known to man, in addition to heparin during char-
coal haernoperfusion carried out for 120 minutes
in healthy dogs. With P012 platelet counts fell
to only 86 + 2.3% of initial compared to 17 +2.7%
when heparin alone was used. P012 preventedany
rise in screen filtration pressuring during char-
coal haemoperfusion (a measure of platelet
aggregate formation) whereas with heparin alone
the screen filtration pressure quadrupled. During
charcoal haernoperfusion with heparin only the
plasma fibrinogen levels fell to 54 + 4% of
initial but with heparin plus POT2 tie plasma
fibrinogen levels were maintained at 92 + 3.8%.
Furthermore the use of P012 prolonged th
activity of heparin as measured by thrombin
clotting time during charcoal haemoperfusion.
This dramatic improvement in biocoripatibility
during charcoal haemoperfusion when P012 is used
may allow more satisfactory assessment of its use
for detoxification.
PLASMA INHISITORS OF THE ERYTHROCYTE HEXOSE—
MONOPHOSPHATE SHUNT IN URAEMIA.J. Zingraff, P. Kamoun, P. Lebreton, T. Drieke,
N.K. Man, P. Jungers.
Ddpartements de NZphrologie et de Biochimie,
HOpital Necker, Paris, France.
The sulfhaemoglobin production has been
studied in red blood cells incubated at 37'C in
the presence of ascorbate and cyanide, a mixture
that induces an oxidative stress. Sulfhaemo—
globin is measured by spectrophotometry. Results
are expressed as the ratio of optic density of
sulfhaemoglobin/total haemoglobin (SH/H). The
mean (+ SEM) ratio found was 0.56 + 0.03 in 51
uraemic subjects and 0.35 + 0.03 in 28 controls
(p<O.OOI). Erythrocytes from uraemic patients,
have been incubated in autologous and in hetero—
logous non uraemic plasma. Uraemic plasma inhibit-
ed the hexose monophosphate (HMP) shunt in uraemio
erythrocytes as well as in non uraemic control
red blood cells. In Vitro studies using normal
erythrocytes incubated in autologous plasma
demonstrated, after addition of guanidino—
propionic acid to a final concentration of
20pmol/L, a significant inhibition of the
shunt. Such an inhibition was not observed after
addition of three other guanidinic compounds.
These data strongly suggest that inhibition
of the erythrocyte liMP shunt in uraemic subjects
may be due, to increased plasma levels of guanidi—
no—propionic acid. A prospective study including
determinations of plasma concentration of this
metabolite in uraemic subjects is in progress.
